Document:

Exhibit
4.2

 

THIS
WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR QUALIFIED UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE
TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION
OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD IN ACCORDANCE WITH RULE
144 UNDEr SUCH ACT. 

 

The
shares of the common stock of the company issuable upon exercise of the warrants represented by this certificate are subJEct to
the preferences, powers, qualifications and rights of each class and series as set forth in the company’s articles of amendment
and restatement, as amended, supplemented or amended and restated, and amended and restated bylaws, as amended, supplemented or
amended and restated. The company shall furnish a copy of the foregoing instruments and any relevant amendments thereto to the
holder of this certificate upon written request.

 

Warrant Certificate No. B-2

Date of Issuance: May 7, 2020

Expiration Date: May 7, 2025

 

Warrant Certificate

 

GREAT AJAX CORP.

 

This Warrant Certificate
(this “Warrant Certificate”) certifies that                             
or its registered assigns (the “Holder”), for value received, is the registered holder of such number of warrants
(“warrants”) as is set forth in the electronic, book-entry records of American Stock Transfer & Trust Company,
LLC, in its capacity as warrant agent for the warrants (the “Warrant Agent”). The warrants are exercisable for
the purchase of shares of common stock, par value $0.01 per share (“Common Stock”), of GREAT AJAX CORP.,
a Maryland corporation (the “Company”), in accordance with the provisions of Section 1 hereof and the Warrant
Agency Agreement, dated May 4, 2020 (the “Warrant Agreement”), by and between the Company and the Warrant Agent.
This Warrant Certificate and the warrants represented hereby are issued pursuant to that certain Securities Purchase Agreement,
dated as of May 7, 2020, by and among the Company, Great Ajax Operating Partnership L.P. and the Holder (the “Securities
Purchase Agreement”), pursuant to which the Company sold two series of warrants and two series of preferred stock (the
 “Preferred Stock”). References in this Warrant Certificate to this “Warrant” shall mean any
and all warrants represented and outstanding under this Warrant Certificate in the Warrant Agent’s records.

 

     

     

    

 

1.                 
EXERCISE.

 

(a)              
Number and Exercise Price of Warrant Shares; Expiration Date. Subject to the terms and conditions set forth herein
and in the Warrant Agreement, each warrant entitles the Holder upon exercise to receive from the Company one fully paid and nonassessable
share of Common Stock of the Company, as may be adjusted from time to time pursuant to the terms herein (the “Warrant
Shares”), at an initial purchase price of $10.00 per share (the “Exercise Price”), on or after the
earlier of (i) the date of effectiveness of the Resale Registration Statement (as such term is defined in the Securities Purchase
Agreement) and (ii) November 7, 2020 (the six-month anniversary of May 7, 2020 (the “Date of Issuance”)), and
on or before 5:00 p.m., Eastern Time, on the fifth (5th) anniversary of the Date of Issuance (the “Expiration
Date”) (subject to earlier termination as set forth herein).

 

(b)              
Cash Exercise. While this Warrant remains outstanding and exercisable in accordance with Section 1(a) above,
the Holder may exercise this Warrant in accordance with Section 6 herein and the applicable terms of the Warrant Agreement,
by wire transfer to the Warrant Agent or by certified or official bank check in U.S. dollars made payable to the order of the Warrant
Agent at the office of the Warrant Agent designated for such purposes. Notwithstanding anything herein to the contrary, the Holder
shall physically surrender this Warrant Certificate to the Warrant Agent for cancellation within three Trading Days (as defined
in Section 3(e)(iii)) of the date the final Notice of Exercise (as defined below) is delivered to the Warrant Agent. In
the case of partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
hereunder, upon request of the Holder, a new Warrant Certificate evidencing the number of Warrants equivalent to the number of
Warrants remaining unexercised may be issued by the Warrant Agent to the Holder of such Warrant Certificate or his duly authorized
assigns in accordance with Section 12 hereof, subject to the provisions of Section 6 of the Warrant Agreement. The Warrant Agent
shall maintain records showing the number of Warrant Shares purchased and the date of such purchases.

 

(c)              
Net Exercise. In lieu of exercising this Warrant pursuant to Section 1(b), at any time, the Holder may elect
to credit the Exercise Price against the Fair Market Value (as defined below) of the Warrant Shares at the time of exercise (the
 “Net Exercise”) pursuant to this Section 1(c) and the Warrant Agreement. If the Company shall receive
written notice from the Holder at the time of exercise of this Warrant that the Holder elects to Net Exercise this Warrant, the
Company shall deliver such written notice to the Warrant Agent pursuant to the terms of the Warrant Agreement. Pursuant to the
terms and conditions of the Warrant Agreement, the Warrant Agent shall deliver to such Holder (without payment by the Holder of
any exercise price in cash) that number of Warrant Shares computed using the following formula:

 

 

     

     

    

 

where

 

		X =	The number of Warrant Shares to be issued to the Holder.

 

		Y =	The number of Warrant Shares purchasable under this Warrant or, if only a portion of this Warrant
is being exercised, the portion of this Warrant being cancelled (at the date of such calculation).

 

		A =	The Fair Market Value of one share of Common Stock on the trading date immediately preceding the
date on which the Holder elects to exercise this Warrant.

 

		B =	The Exercise Price (as adjusted hereunder).

 

The “Fair
Market Value” of one share of Common Stock shall mean (x) the last reported sale price on the New York Stock Exchange
and, if there are no sales, the last reported bid price, of the Common Stock on the business day prior to the date of exercise
on the Trading Market (as defined below) on which the Common Stock is then listed or quoted as reported by Bloomberg Financial
Markets (“Bloomberg”) or (y) if the Fair Market Value cannot be calculated as of such date on the foregoing
basis, the price determined in good faith by the Company’s board of directors.

 

“OTC Markets”
shall mean either OTCQX or OTCQB of the OTC Markets Group Inc.

 

“Trading Market”
shall mean any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question:
the New York Stock Exchange, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE American
or the OTC Markets (or any successors to any of the foregoing).

 

(d)              
Deemed Exercise. In the event that immediately prior to the close of business on the Expiration Date, the Fair Market
Value of one share of Common Stock (as determined in accordance with Section 1(c) above) is greater than the then applicable
Exercise Price, this Warrant shall be deemed to be automatically exercised on a Net Exercise basis pursuant to Section 1(c)
above, and the Company shall deliver the applicable number of Warrant Shares to the Holder pursuant to the provisions of Section
1(c) above and this Section 1(d).

 

(e)              
Holder’s Exercise Limitations. Notwithstanding anything to the contrary contained herein, the number of Warrant
Shares that may be acquired by the Holder upon any exercise of this Warrant (or otherwise in respect hereof) shall be limited to
the extent necessary to ensure that, following such exercise (or other issuance), the total number of shares of Common Stock then
beneficially owned by such Holder does not exceed the Ownership Limits (as defined below), unless the Company’s board of
directors has, in its sole discretion, granted the Holder a waiver from the stock ownership limitations set forth in the Company’s
charter. The parties hereto acknowledge that certain listing standards of the Trading Market may generally require the Company
to obtain the approval of its stockholders before entering into certain transactions that potentially result in the issuance of
20% or more of its outstanding Common Stock; accordingly, in the event of an exercise of this Warrant that would result in the
total number of shares of Common Stock then beneficially owned by a Holder and any Affiliate of such Holder exceeding 19.9% of
the total number of then issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable
upon such exercise), the Company shall, at its discretion, either obtain stockholder approval of such issuances or upon settlement
of the exercise of such Warrant deliver cash in lieu of any shares otherwise deliverable upon exercise of such Warrant in excess
of such limitation, in accordance with the provisions of Section 6(a) hereof.

 

     

     

    

 

		2.	CERTAIN ADJUSTMENTS.

 

(a)              
Adjustment of Number of Warrant Shares and Exercise Price. The number and kind of Warrant Shares purchasable upon
exercise of this Warrant and the Exercise Price shall be subject to adjustment from time to time as follows:

 

(i)                
Dividends, Subdivisions, Combinations and Other Issuances. If the Company shall at any time after the Date of Issuance
but prior to the Expiration Date subdivide its shares of capital stock of the same class as the Warrant Shares, by stock split
or otherwise, or combine such shares of capital stock, effect a reverse stock split, pay a dividend or issue additional shares
of capital stock as a dividend with respect to any shares of such capital stock, the number of Warrant Shares issuable on the exercise
of this Warrant shall forthwith be proportionately increased in the case of a subdivision, dividend or stock dividend, or proportionately
decreased in the case of a combination or reverse stock split. Appropriate adjustments shall also be made to the Exercise Price
payable per share, but the aggregate Exercise Price payable for the total number of Warrant Shares purchasable under this Warrant
(as adjusted) shall remain the same. Any adjustment under this Section 2(a)(i) shall become effective at the close of business
on the date the subdivision or combination becomes effective, or as of the record date of such dividend, or in the event that no
record date is fixed, upon the making of such dividend.

 

(ii)             
Reclassification, Reorganizations and Consolidation. In case of any reclassification, capital reorganization or change
in the capital stock of the Company (other than as a result of a subdivision, combination, stock split (forward or reverse) or
stock dividend provided for in Section 2(a)(i) above) that occurs after the Date of Issuance, then, as a condition of such
reclassification, reorganization or change, lawful provision shall be made, and duly executed documents evidencing the same from
the Company or its successor shall be delivered to the Holder, so that the Holder shall thereafter have the right at any time prior
to the expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise of this Warrant, the kind
and amount of shares of stock and/or other securities or property (including, if applicable, cash) receivable in connection with
such reclassification, reorganization or change by a holder of the same number and type of securities as were purchasable as Warrant
Shares by the Holder immediately prior to such reclassification, reorganization or change. In any such case, appropriate provisions
shall be made with respect to the rights and interest of the Holder so that the provisions hereof shall thereafter be applicable
with respect to any shares of stock or other securities or property deliverable upon exercise hereof, and appropriate adjustments
shall be made to the Exercise Price payable hereunder, provided the aggregate Exercise Price shall remain the same (and, for the
avoidance of doubt, this Warrant shall be exclusively exercisable for such shares of stock and/or other securities or property
from and after the consummation of such reclassification or other change in the capital stock of the Company).

 

(b)              
Calculations. All calculations under this Section 2 shall be made to the nearest cent or the nearest 1/100th
of a share, as the case may be. For purposes of this Section 2, the number of shares of Common Stock deemed to be issued
and outstanding as of a given date shall be the sum of the number of shares of Common Stock issued and outstanding.

 

     

     

    

 

(c)              
Treatment of Warrant upon a Change of Control.

 

(i)                
If, at any time while this Warrant is outstanding, the Company consummates a Change of Control, then a Holder shall have
the right thereafter to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it
would have been entitled to receive upon the occurrence of such Change of Control if it had been, immediately prior to such Change
of Control, a holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant (the “Alternate
Consideration”). The Company shall not effect any such Change of Control unless prior to or simultaneously with the consummation
thereof, any successor to the Company, surviving entity or the corporation purchasing or otherwise acquiring such assets or other
appropriate corporation or entity shall assume the obligation to deliver to the Holder, such Alternate Consideration as, in accordance
with the foregoing provisions, the Holder may be entitled to purchase, and the other obligations under this Warrant.

 

(ii)             
As used in this Warrant, a “Change of Control” means (i) a consolidation, merger or combination or statutory
share exchange, in each case involving the Company, (ii) a sale of all or substantially all of the direct or indirect assets of
the Company (including by way of any reorganization, merger, consolidation or other similar transaction) or (iii) a direct or indirect
acquisition of beneficial ownership of voting securities of the Company by another person or “group” (within the meaning
of Rules 13d-3 and 13d-5 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) by means
of any transaction or series of transactions (including any reorganization, merger, consolidation, joint venture, share transfer
or other similar transaction), in each case, pursuant to which (x) the stockholders of the Company immediately preceding such transaction
or transactions collectively own, following the consummation of such transaction or transactions, less than fifty percent (50%)
of the total economic interests or total voting power of all securities of beneficial interest of the Company entitled to vote
generally and / or (y) as a result of which the Common Stock would be converted into, or exchanged for, or would be reclassified
or changed into, stock, other securities, other property or assets (including cash or any combination thereof).

 

3.                 
PUT OPTION.

 

(a)              
Subject to the limitations provided in this Section 3, the Holder shall have the option (the “Put Option”),
but not the obligation, to sell to the Company, in whole or in part, the warrants represented by the Warrant Certificate at a price
per warrant equal to the Put Price, and on the terms set forth in this Section 3. “Put Price” means an
amount equal to the product of (i) the number of Shares (as such term is defined in the Securities Purchase Agreement) held by
the Holder at the time of exercise of the Put Option calculated as discussed in (b) below, (ii) $25.00, (iii) 0.13, (iv) the
greater of (A) 3.25 and (B) the number of years (or a fraction thereof computed on the basis of a 360-day year comprised of twelve
30-day months) during which the Holder actually held such Shares as of the time of exercise of the Put Option (provided that this
number shall also include the holding period of the predecessors in interest of the Holder with respect to the Shares) and (v)
a fraction, the numerator of which is one and the denominator of which is the total number of warrants first issued by the Company
to the Holder (or its predecessor in interest) on the Date of Issuance.

 

(b)              
The Put Option may be exercised at any time on or after August 7, 2023. If prior to the time of exercise of the Put Option,
the Holder has sold any Shares, then solely for the purpose of calculating the number of Shares held by the Holder at such time,
such previously sold Shares shall be deemed to be held by the Holder at such time of exercise.

 

     

     

    

 

(c)              
The Put Option may be exercised only by the Holder delivering written notice of exercise to the Company specifying the number
of warrants to be sold pursuant to the Put Option (the “Put Notice”). The Company shall be obligated to purchase
from the Holder and cancel, and the Holder shall be obligated to sell to the Company, this Warrant or the portion thereof specified
in the Put Notice within 10 days of the Company’s receipt of the Put Notice (the “Put Notice Period”);
provided that such period may be mutually extended by the Company and the Holder as necessary to accommodate the determination
of the Put Price. For the avoidance of doubt, the Put Notice Period and the Put Option Closing Date (as defined below) may occur
after the Expiration Date, provided that the Put Notice is delivered prior to the close of business on the Expiration Date.
During the Put Notice Period, the Holder shall not take any action that has caused or will cause the Holder to have, directly or
indirectly, effected or agreed to effect any short sale, whether or not against the box, established any “put equivalent
position” (as defined in Rule 16a-1(h) under the Exchange Act with respect to the Common Stock), granted any other right
(including, without limitation, any put or call option) with respect to the Common Stock or with respect to any security that includes,
relates to or derived any significant part of its value from the Common Stock.

 

(d)              
If the Put Option is exercised, the closing of the required purchase and sale of this Warrant shall occur on the 10th day
following the delivery of the Put Notice or at such other time as may be mutually agreed between the Company and the Holder (the
 “Put Option Closing Date”). At the closing, and subject to the limitations on issuance of the Company’s
stock that apply in the case of an exercise of this Warrant under Section 1(e), the Company shall pay the Holder the Put
Price in cash or Common Stock or a combination of cash and Common Stock, provided that if the number of Common Shares to
be issued and paid to the Holder as the Put Price would result in the Holder beneficially or constructively owning either a total
number of shares of (i) Common Stock in excess of the Common Stock Ownership Limit (as defined and determined in accordance with
the Company’s Articles of Amendment and Restatement, as amended (“Charter”)) or (ii) Capital Stock (as
defined in the Charter) in excess of the Aggregate Stock Ownership Limit (as defined and determined in accordance with the Charter,
and together with the Common Stock Ownership Limit, the “Ownership Limits”), then the Company shall either deliver
cash in lieu of any shares otherwise deliverable in excess of such Ownership Limits, or grant a waiver to such Holder from the
Ownership Limits so as to permit the payment of such shares of Common Stock under the Charter but only to the extent such Holder
is not an individual and such waiver does not result in the total number of shares of Capital Stock then beneficially or constructively
owned by any direct or indirect owner of such Holder who is treated as an individual pursuant to Sections 542(a)(2) and 544 of
the United States Internal Revenue Code of 1986, as amended (the “Code”), as those sections are used in Section
856(h) of the Code and determined pursuant to Section 6.2.1 of the Charter, exceeding the Ownership Limits, provided further,
that, the number of shares of Common Stock that may be issued to the Holder upon exercise of the Put Option shall be limited
to the extent necessary to ensure that, following such exercise, the total number of shares of Common Stock then beneficially owned
by such Holder does not exceed 19.9% of the total number of issued and outstanding shares of Common Stock (including for such purpose
the shares of Common Stock issuable upon such exercise), unless the Company obtains stockholder approval of the issuances of any
such shares of Common Stock then beneficially owned by a Holder and any Affiliate of such Holder exceeding 19.9% of the total number
of then issued and outstanding shares of Common Stock (including for such purpose the shares of Common Stock issuable upon such
exercise). Within three days of the delivery of the Put Notice by the Holder to the Company, the Company will provide written notice
to the Holder of its election to pay the Put Price to the Holder in cash, Common Stock or a specified combination thereof; provided
that if the Company elects to make any portion of the payment of the Put Price in the form of Common Stock, each share of such
Common Stock shall be valued for purposes of payment of the Put Price at its Final Average Trading Price corresponding to the Put
Option Closing Date.

 

     

     

    

 

(e)              
The following defined terms shall be employed in the determination of Final Average Trading Price for purposes of Sections
3(d) and 6(a): (i) “Daily Dollar Trading Volume” for each Trading Day during any period, means
the Volume-Weighted Average Daily Price for such Trading Day multiplied by the aggregate number of shares of Common Stock traded
on such Trading Day; (ii) “Final Average Trading Price” means the Weighted Average Period Price of the
Common Stock for the period of 10 Trading Days ending immediately prior to the date that is two business days prior to the Put
Option Closing Date or the Warrant Share Delivery Date, as the case may be; (iii) “Trading Day” means a
day during which trading in securities generally occurs on the Trading Market; (iv) “Weighted Average Period Price”
of the Common Stock for any period means the quotient of (A) the sum of the Daily Dollar Trading Volume for each day during such
period divided by (B) the aggregate number of shares of Common Stock traded during such period; and (v) “Volume-Weighted
Average Daily Price,” on any Trading Day, means the volume-weighted average price for the Common Stock on the Trading
Market, during the period beginning at 9:30:01 a.m., Eastern Time (or such other time as is the official open of trading at the
Trading Market), and ending at 4:00:00 p.m., Eastern time (or such other time as is the official close of trading at the Trading
Market), as reported by Bloomberg through its “Volume at Price” function (or any successor function, or if there is
no such function or such successor function, then as calculated by a nationally recognized investment bank selected by the Company).
The volume-weighted average price shall be rounded to the nearest whole cent.

 

(f)               
Whenever the Holder sells or otherwise transfers any shares of Preferred Stock held by the Holder, the Holder shall immediately
send a notification of such sale or transfer to the Company setting forth in reasonable detail a description of such sale or transfer,
including without limitation, the date on which such sale or transfer is expected to become effective or consummated.

 

(g)              
The Holder shall execute such instruments and other documents as reasonably requested by the Company to evidence the sale,
provided that: (i) the Company shall bear any and all reasonable costs and expenses incurred by the Holder in connection
with the exercise of the Put Option and related sale of this Warrant, and (ii) the Holder shall not be required to make any representations
or warranties in connection with such sale other than representations and warranties with respect to title of this Warrant being
sold, authority to sell this Warrant and such matters pertaining to compliance with securities laws by the Holder as may be reasonably
requested by the Company.

 

     

     

    

 

4.                 
NO FRACTIONAL SHARES; CHARGES, TAXES AND EXPENSES. No fractional Warrant Shares or scrip representing fractional shares
will be issued upon exercise of this Warrant. In lieu of any fractional shares which would otherwise be issuable, the Company shall
pay cash equal to the product of such fraction multiplied by the Fair Market Value of one Warrant Share. Issuance of Warrant Shares
shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance
of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in
the name of the Holder or in such name or names as may be directed by the Holder; provided, however, that in the
event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise
shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all fees
required for same-day processing of any Notice of Exercise and all fees to The Depository Trust Company (or another established
clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

5.                 
NO STOCKHOLDER RIGHTS. Until the exercise of this Warrant or any portion of this Warrant, the Holder shall not have, nor
exercise, any rights as a stockholder of the Company (including without limitation the right to notification of stockholder meetings
or the right to receive any notice or other communication concerning the business and affairs of the Company).

 

6.                 
MECHANICS OF EXERCISE.

 

(a)              
Delivery of Warrant Shares Upon Exercise. This Warrant may be exercised by the Holder hereof, in whole or in part,
by delivering to the Warrant Agent at the office of the Warrant Agent designated for such purposes, in the case of a cash exercise,
and to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder
at the address of the Holder appearing on the books of the Company), in the case of a net exercise, a duly executed copy of the
Notice of Exercise in the form attached hereto as Exhibit A (the “Notice of Exercise”) by facsimile or
e-mail attachment and paying the Exercise Price (unless the Holder has elected to Net Exercise, if applicable) then in effect with
respect to the number of Warrant Shares as to which the Warrant is being exercised. No ink-original Notice of Exercise shall be
required, nor any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise shall be required.
This Warrant shall be deemed to have been exercised immediately prior to the close of business on the date of the delivery to the
Company of the Notice of Exercise and payment of the Exercise Price (unless the Holder has elected to Net Exercise, if applicable)
as provided above, and the person entitled to receive the Warrant Shares issuable upon such exercise shall be treated for all purposes
as the Holder of such shares of record as of the close of business on such date. Warrant Shares purchased hereunder shall be transmitted
by the Company’s transfer agent to the Holder by crediting the account of the Holder’s prime broker with The Depository
Trust Company through its Deposit and Withdrawal at Custodian system (“DWAC”) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or
resale of the Warrant Shares by the Holder or (B) the shares are eligible for resale by the holder without volume or manner-of-sale
limitations pursuant to Rule 144, and otherwise by electronic book-entry form (unless the Holder requests that the Warrant Shares
be issued in certificated form in the Notice of Exercise) by the end of the day on the date that is two trading days from the delivery
to the Company of the Notice of Exercise and payment of the aggregate Exercise Price (unless exercised by means of a cashless exercise
pursuant to Section 1(c)) (the “Warrant Share Delivery Date”). The Warrant Shares shall be deemed
to have been issued, and the Holder or any other person so designated to be named therein shall be deemed to have become a holder
of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise
Price (or by Net Exercise, if applicable) and all taxes required to be paid by the Holder, if any, prior to the issuance of such
shares, having been paid. The Company may settle the exercise of each Warrant by delivery of Warrant Shares, by payment of cash
in lieu thereof or by a combination thereof. Within three days of the delivery of the Notice of Exercise by the Holder to the Company,
the Company will provide written notice to the Holder of its election to settle the exercise of the exercised Warrants in cash,
Common Stock or a specified combination thereof; provided that if the Company elects to so deliver any cash in lieu of shares
of Common Stock, each share of such Common Stock shall be valued for purposes of such settlement at its Final Average Trading Price
corresponding to the Warrant Share Delivery Date.

 

     

     

    

 

(b)              
Rescission Rights. If the Company fails to cause its transfer agent to transmit to the Holder the Warrant Shares
pursuant to Section 6(a) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

7.                 
CERTIFICATE OF ADJUSTMENT. Whenever the Exercise Price or number or type of securities issuable upon exercise of this Warrant
is adjusted, as herein provided, the Company shall, at its expense, promptly deliver to the Holder a certificate of an officer
of the Company setting forth the nature of such adjustment and showing in detail the facts upon which such adjustment is based.
Whenever the Company makes any announcement or provides any notice to any Person pertaining to any Change of Control or any redemption
of any of its capital stock (including the Preferred Stock), the Company shall, at its expense, immediately send to the Holder
a certificate of an officer of the Company setting forth in reasonable detail a description of such Change of Control or redemption
and any related transactions, including without limitation the date on which such Change of Control or redemption is expected to
become effective or consummated. All certificates required pursuant to this Section 7 shall be provided by facsimile or
electronic mail or by overnight delivery, in each case, in accordance with Section 14(b).

 

8.                 
COMPLIANCE WITH SECURITIES LAWS.

 

(a)              
The Holder understands that this Warrant and the Warrant Shares are characterized as “restricted securities”
under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public
offering and that under such laws and applicable regulations this Warrant and the Warrant Shares may be resold without registration
under the Securities Act of 1933, as amended (the “Securities Act”), only in certain limited circumstances.
In this connection, the Holder represents that it is familiar with Rule 144 under the Securities Act, as presently in effect, and
understands the resale limitations imposed thereby and by the Securities Act.

 

(b)              
Prior and as a condition to the sale or transfer of the Warrant Shares issuable upon exercise of this Warrant, the Holder
shall furnish to the Company such certificates, representations, agreements and other information, as the Company or the Company’s
transfer agent reasonably may require to confirm that such sale or transfer is being made pursuant to an exemption from, or in
a transaction not subject to, the registration requirements of the Securities Act, unless such Warrant Shares are being sold or
transferred pursuant to an effective registration statement.

 

     

     

    

 

(c)              
The Holder acknowledges that the Company may place a restrictive legend on the Warrant Shares issuable upon exercise of
this Warrant in order to comply with applicable securities laws, in substantially the following form and substance, unless such
Warrant Shares are otherwise freely tradable under Rule 144 of the Securities Act:

 

“THE SECURITIES
EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR ANY OTHER APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF
THE SECURITIES ACT AND SUCH OTHER SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED,
SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, HYPOTHECATED OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO A TRANSACTION WHICH IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION, IN
EACH CASE IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS, AND IN THE CASE OF A TRANSACTION EXEMPT FROM, OR NOT SUBJECT TO, SUCH
REGISTRATION, UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSACTION DOES NOT
REQUIRE REGISTRATION UNDER THE SECURITIES ACT AND SUCH OTHER APPLICABLE LAWS.”

 

The Holder also acknowledges
that the Company may place a restrictive legend on the Warrant Shares issuable upon exercise of this Warrant in order to comply
with applicable securities laws, in substantially the following form and substance:

 

“THE SHARES
REPRESENTED BY THIS CERTIFICATE ARE OWNED BY A PERSON OR PERSONS WHO MAY BE CONSIDERED AN AFFILIATE FOR PURPOSES OF RULE 144 UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). NO OFFER, SALE, TRANSFER OR ASSIGNMENT OF THESE SHARES OR ANY INTEREST
THEREIN MAY BE MADE UNLESS THE ISSUER HAS RECEIVED AN OPINION OF COUNSEL SATISFACTORY TO IT THAT THE SHARES MAY BE SOLD PURSUANT
TO RULE 144 UNDER THE ACT OR ANOTHER APPLICABLE EXEMPTION FROM REGISTRATION UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.”

 

9.                 
REPLACEMENT OF WARRANTS. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this Warrant and, in the case of any such loss, theft or destruction of this Warrant, on delivery of an indemnity
agreement reasonably satisfactory in form and amount to the Company (but not the posting of any surety or other bond) or, in the
case of any such mutilation, on surrender and cancellation of such Warrant, the Company at its expense will execute and deliver,
in lieu thereof, a new Warrant of like tenor.

 

     

     

    

 

10.             
NO IMPAIRMENT. Except to the extent as may be waived by the Holder, the Company will not, by amendment of its charter or
through a Change of Control, dissolution, sale of assets or any other voluntary action, avoid or seek to avoid the observance or
performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms
and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the Holder against impairment.

 

11.             
TRADING DAYS. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall be other than a day on which the Common Stock is traded on the Trading Market, then such action may be taken or such
right may be exercised on the next succeeding day on which the Common Stock is so traded.

 

12.             
TRANSFERS; EXCHANGES.

 

(a)              
Subject to compliance with applicable federal and state securities laws and Section 8 hereof, this Warrant may only
be transferred by the Holder to an Affiliate of the Holder (a “Permitted Transfer”). For a transfer of this
Warrant as an entirety by the Holder, upon surrender of this Warrant to the Company, together with the Notice of Assignment in
the form attached hereto as Exhibit B duly completed and executed on behalf of the Holder, the Company shall issue a new
Warrant of the same denomination to the assignee. For a transfer of this Warrant with respect to a portion of the Warrant Shares
purchasable hereunder, upon surrender of this Warrant to the Company, together with the Notice of Assignment in the form attached
hereto as Exhibit B duly completed and executed on behalf of the Holder, the Company shall issue a new Warrant to the assignee,
in such denomination as shall be requested by the Holder, and shall issue to the Holder a new Warrant covering the number of shares
in respect of which this Warrant shall not have been transferred. The term “Affiliate” as used herein means,
with respect to any person, any other person that, directly or indirectly through one or more intermediaries, controls, is controlled
by or is under common control with such person, and any officers, employees or partners of the Holder.

 

(b)              
Upon any Permitted Transfer, this Warrant is exchangeable, without expense, at the option of the Holder, upon presentation
and surrender hereof to the Company for other warrants of different denominations entitling the holder thereof to purchase in the
aggregate the same number of shares of Common Stock purchasable hereunder. This Warrant may be divided or combined with other warrants
that carry the same rights upon presentation hereof at the principal office of the Company together with a written notice specifying
the denominations in which new warrants are to be issued to the Holder and signed by the Holder hereof. The term “Warrants”
as used herein includes any warrants into which this Warrant may be divided or exchanged.

 

13.             
AUTHORIZED SHARES. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of
any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority
to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights
under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may
be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market
upon which the Common Stock may be quoted or listed. The Company covenants that all Warrant Shares which may be issued upon the
exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant
and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and
free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).

 

     

     

    

 

		14.	MISCELLANEOUS.

 

(a)              
Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the United States
of America and the State of New York, both substantive and remedial, without regard to New York conflicts of law principles. Any
judicial proceeding brought under this Agreement or any dispute arising out of this Agreement or any matter related hereto shall
be brought in the courts of the State of New York, New York County, or in the United States District Court for the Southern District
of New York.

 

(b)              
Notices. All notices, requests, consents and other communications hereunder shall be in writing, shall be sent by
confirmed facsimile or electronic mail, or mailed by first-class registered or certified airmail, or nationally recognized overnight
express courier, postage prepaid, and shall be deemed given when so sent in the case of facsimile or electronic mail transmission,
or when so received in the case of mail or courier, and addressed as follows: (a) if to the Company, at Great Ajax Corp., 9400
SW Beaverton-Hillsdale Hwy, Suite 131, Beaverton, Oregon 97005, Attn: Lawrence Mendelsohn, e-mail: larry@aspencapital.com; with
a copy to (which shall not constitute notice) Mayer Brown LLP, 1221 Avenue of the Americas, New York, New York 10020, Attn: Anna
T. Pinedo, Esq., e-mail: apinedo@mayerbrown.com, (b) to the Warrant Agent, at American Stock Transfer & Trust Company, LLC,
6201 15th Avenue, Brooklyn, New York 11219, e-mail: reorgwarrants@astfinancial.com, with a copy to American Stock Transfer
 & Trust Company, LLC, 48 Wall Street, 22nd Floor, New York, New York 10005, Attn: Legal Department, e-mail: legalteamAST@astfinancial.com,
and (c) if to the Holder, at such address or addresses (including copies to counsel) as may have been furnished by the Holder to
the Company in writing.

 

(c)              
The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any
other provisions.

 

(d)              
No Voting Rights; Limited Dividend Rights. Nothing contained in this Warrant shall be construed as conferring upon
the Holder hereof the right to vote or to consent to receive notice as a stockholder of the Company or any other matters or any
rights whatsoever as a stockholder of the Company. No dividends or interest shall be payable or accrued in respect of this Warrant
or the interest represented hereby or the interests purchasable hereunder until, and only to the extent that, this Warrant shall
have been exercised.

 

     

     

    

 

(e)              
Tax Treatment.

 

(i)                
Unless otherwise required by applicable law, the Company and the Holder agree to treat the Warrant as a debt instrument
for U.S. federal income tax purposes with a stated interest rate of 0%, a maturity date of August 7, 2023, and such issue price
and stated redemption price at maturity as set forth for the Holder under Schedule III of the Securities Purchase Agreement.

 

(ii)             
The Company shall maintain a register for the recordation of the names and addresses of each Holder, and the percentage
or portion of such rights and obligations assigned, including the principal amounts (and stated interest) of each Holder from time
to time (the “Register”). Any Warrant may only be transferred in compliance with Section 12 hereof and upon
surrender of such Warrant and the issuance by the Company of a new Warrant (or through a book-entry system), which is intended
to comply with U.S. Treasury Regulations Section 1.871-14(c) and Proposed Regulations Section 1.871-14(c). The Register is intended
to establish that the Warrant is in registered form within the meaning of United States Treasury Regulation Section 5f.103-1(c)
and Proposed Regulation Section 1.163-5(b).

 

(iii)           
The Company shall be entitled to deduct and withhold from any amounts payable under the Warrant such amounts as the Company
is required to deduct and withhold under the Code or any provision of applicable law. The Company does not intend to make any deduction
or withholding under the Code of any provision of applicable law so long as it receives from the Holder (1) any complete and correct
applicable IRS Form W-9, W-8BEN, W-8BEN-E, W-8ECI or W-8IMY (with any applicable attachments) and (2) any documentation that is
required under Sections 1471-1474 of the Code to enable the Company to determine its duties and liabilities with respect to any
taxes it may be required to withhold in respect of such Warrant or Holder.

 

[Signature Page Follows]

 

     

     

    

 

IN WITNESS WHEREOF, each of the Company
and the Warrant Agent has caused this Warrant Certificate to be duly executed as of the date first above written.

 

	 	GREAT AJAX CORP.
	 	 	 
	 	By:	          
	 	Name: Russell Schaub
	 	Title: President
	 	 	 
	 	AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, as Warrant Agent.
	 	 	 
	 	 	 
	 	By:	         
	 	Name:
	 	Title:

 

[Signature page to Warrant]

     

     

    

 

EXHIBIT A

 

NOTICE OF EXERCISE

(To be signed only upon exercise of Warrant)

 

To:__________________________

 

 

The undersigned, the
holder of a right to purchase common stock, par value $0.01 per share (“Common Stock”), of GREAT AJAX CORP.,
a Maryland corporation (the “Company”), pursuant to the attached Warrant to Purchase Shares of Common Stock
of Great Ajax Corp. (the “Warrant”), dated as of May 7, 2020, hereby irrevocably elects to exercise the purchase
right represented by such Warrant for, and to purchase thereunder, ______________________________ (_________) shares of Common
Stock and (choose one):

 

		1)	_______ herewith makes payment of ______________________________ Dollars ($__________) therefor
by wire transfer of immediately available funds to the account designated below by the Company.

 

Amount of Transfer: $________________

Date of Transfer: ________, 20__

Bank: [•]

ABA Number: [•]

A/C Number: [•]

A/C Name: [•]

Ref: [•]

ATT: [•]

 

OR

 

		2)	_______ herewith elects to Net Exercise the Warrant pursuant to Section 1(c) thereof.

 

The undersigned
requests that the certificates or book entry position representing the shares of Common Stock to be acquired pursuant to such
exercise be issued in the name of, and delivered to __________________________________________, whose address is
_________________________________________________________.

 

     

     

    

 

By its signature below
the undersigned hereby represents and warrants that it is an “accredited investor” as defined in Rule 501(a) of Regulation
D promulgated under the Securities Act of 1933, as amended, and agrees to be bound by the terms and conditions of the attached
Warrant as of the date hereof, including Section 8 thereof.

 

DATED: ________________

 

	 	[NAME OF HOLDER]
	 	 	 
	 	By:	
	 	 	 
	 	Name:	
	 	 	 
	 	Its:	          

 

[Signature page to Notice of Exercise]

 

     

     

    

 

EXHIBIT B

 

NOTICE OF ASSIGNMENT FORM

 

FOR VALUE RECEIVED, [_________] (the
 “Assignor”) hereby sells, assigns and transfers all of the rights of the undersigned Assignor under the attached
Warrant with respect to the number of shares of common stock of GREAT AJAX CORP., a Maryland corporation (the “Company”),
covered thereby set forth below, to the following “Assignee” and, in connection with such transfer, represents
and warrants to the Company that the transfer is in compliance with Sections 8 and 12 of the Warrant and applicable federal
and state securities laws:

 

	NAME OF ASSIGNEE:	 	ADDRESS/FAX NUMBER:
	 	 	 
	 	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	Number of shares:	 	 	Signature:	 
	 	 	 	 	 
	Dated:	 	 	Witness:	 

 

 

ASSIGNEE ACKNOWLEDGMENT

 

The undersigned Assignee acknowledges that
it has reviewed the attached Warrant and by its signature below it hereby represents and warrants that it is an “accredited
investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended, and agrees
to be bound by the terms and conditions of the Warrant as of the date hereof, including Section 7 thereof.

 

	 	Signature:	 
	 	 	 
	 	By:	 
	 	Title:	 

 

 

	Address:Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase
Agreement (this “Agreement”) is dated as of May 7, 2020, among Great Ajax Corp., a Maryland corporation (the
 “Company”), Great Ajax Operating Partnership LP, a Delaware limited partnership (the “Operating Partnership”),
Thetis Asset Management LLC, a Delaware limited liability company (the “Manager”), and the purchasers set forth
in Schedule I hereto (the “Purchasers”). Magnetar Xing He Master Fund Ltd. and Magnetar SC Fund Ltd.
join this Agreement solely for purpose of Section 4.1 below.

 

NOW, THEREFORE, IN
CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the Company, the Operating Partnership, the Manager and the Purchasers hereby agree
as follows:

 

ARTICLE
I.

PURCHASE AND SALE

 

1.1             
Closing.

 

(a)              
On the Closing Date (as defined below), upon the terms and subject to the conditions set forth herein, the Company agrees
to sell or issue, as applicable, and the Purchasers agrees to purchase or accept, as applicable: (a) 1,112,400 shares (the
 “Series A Shares”) of the Company’s 7.25% Series A Fixed-to-Floating Rate Preferred Stock, liquidation
preference $25.00 per share (the “Series A Preferred Stock”); (b) 87,600 shares (the “Series B
Shares,” and together with the Series A Shares, the “Shares”) of the Company’s 5.00% Series
B Fixed-to-Floating Rate Preferred Stock, liquidation preference $25.00 per share (the “Series B Preferred Stock,”
and together with the Series A Preferred Stock, the “Preferred Stock”); (c) two series of warrants (the
 “Series A Warrant” and the “Series B Warrant,” and together the “Warrants”)
issued and delivered pursuant to the Warrant Agency Agreement, dated as of May 4, 2020 (the “Warrant Agency Agreement”),
between the Company and American Stock Transfer & Trust Company, LLC, in its capacity as the Company’s warrant agent
for the Warrants (the “Warrant Agent”), and in connection with the Closing under this Agreement to purchase
1,500,000 shares of common stock, par value $0.01 per share (“Common Stock”), for an aggregate purchase price
of $30,000,000 (the “Aggregate Purchase Price”). The Warrants and the Shares are hereinafter collectively called
the “Securities.”

 

(b)              
On the Closing Date, the Company shall issue 1,390,500 Series A Warrants in substantially the form attached hereto as Exhibit
A and 109,500 Series B Warrants in substantially the form attached hereto as Exhibit B. The Warrants shall have an exercise
price equal to $10.00 per share of Common Stock, issuable upon exercise of the Warrants (“Warrant Shares”) (subject
to adjustment as provided in such Warrants).

 

     

     

    

 

1.2             
Deliveries.

 

(a)              
The completion of the purchase and sale of the Shares and the Warrants being purchased hereunder (the “Closing”)
shall occur remotely via the exchange of documents and signatures on or prior to May 7, 2020, promptly following the satisfaction
of all conditions for Closing set forth below (the “Closing Conditions”), or on such later date or at such different
location as the parties shall agree to in writing, but not prior to or later than the second business day after the date that the
Closing Conditions have been satisfied or waived by the appropriate party (the “Closing Date”).

 

At the Closing, the
Purchasers shall deliver to an account designated by the Company, via wire transfer of immediately available funds, the Aggregate
Purchase Price as set forth in Section 1.1 above, and the Company shall deliver to each Purchaser (or its designated
custodian per its delivery instructions), (i) the Shares issuable to each Purchaser pursuant to this Agreement in electronic, book-entry
form, registered in the name of such Purchaser, or confirmation of instruction given by the Company to American Stock Transfer
 & Trust Company, LLC, in its capacity as the Company’s transfer agent for the Preferred Stock (as defined herein) (the
 “Transfer Agent”), to register the Shares in electronic, book-entry form with respect to, the number of Shares
set forth in Section 1.1 above and bearing an appropriate legend referring to the fact that the Shares were sold in reliance
upon the exemption from registration under the Securities Act of 1933, as amended (the “Securities Act”), provided
by Section 4(a)(2) thereof; and (ii) the Series A Warrant and Series B Warrant, each registered in the name of the applicable Purchaser
in electronic, book-entry form with the Warrant Agent, in substantially the forms attached hereto as Exhibit A and Exhibit
B, respectively, representing the number of shares of Common Stock set forth in Section 1.1 above and bearing an
appropriate legend referring to the fact that the Warrants were sold in reliance upon the exemption from registration under the
Securities Act provided by Section 4(a)(2) thereof.

 

1.3             
Closing Conditions.

 

(a)              
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

 

(i)                
the accuracy in all material respects on the Closing Date of the representations and warranties made by the Purchasers (unless
as of a specific date therein in which case they shall be accurate as of such date);

 

(ii)             
the fulfillment in all material respects of those undertakings of the Purchasers to be fulfilled prior to the Closing;

 

(iii)           
receipt by the Company of the Registration Rights Agreement, dated as of the Closing Date, between the Company and the Purchasers,
a form of which is attached hereto as Exhibit C (the “Registration Rights Agreement”), which shall have
been duly executed by the Purchasers;

 

(iv)            
receipt by the Company of a wire transfer to the account designated by the Company of same-day funds in the full amount
of the Aggregate Purchase Price for the Shares and the Warrants being purchased hereunder; and

 

(v)              
receipt by the Company of an applicable IRS Form W-8 or W-9 from each of the Purchasers.

 

    	 	2	 

     

    

 

(b)              
The obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being
met:

 

(i)                
the accuracy in all material respects when made and on the Closing Date of the representations and warranties of the Company
and the Operating Partnership contained herein (unless as of a specific date therein, in which case they shall be accurate as of
such date);

 

(ii)             
the fulfillment in all material respects of those undertakings of the Company to be fulfilled prior to the Closing, including
filing (i) Articles Supplementary classifying and designating the Preferred Stock (the “Second Closing Articles Supplementary”)
and (ii) Articles of Amendment (the “Articles of Amendment”) amending (the “Amendment”) the
First Closing Articles Supplementary (as defined below), in each case with the State Department of Assessments and Taxation of
Maryland (the “SDAT”);

 

(iii)           
receipt by the Purchasers of a legal opinion from Mayer Brown LLP, counsel to the Company, the Operating Partnership and
the Manager addressed to the Purchasers and dated the Closing Date substantially in the form of Exhibit D hereto, including
an opinion as to the status of the Company as a real estate investment trust (a “REIT”);

 

(iv)            
receipt by the Purchasers of the Registration Rights Agreement, which shall have been duly executed by the Company; and

 

(v)              
receipt by the Purchasers of a cross-receipt executed by the Company and delivered to the Purchasers certifying that it
has received from the Purchasers an amount in cash equal to the Aggregate Purchase Price.

 

ARTICLE
II.

REPRESENTATIONS AND WARRANTIES

 

2.1             
Representations, Warranties and Covenants of the Company and the Operating Partnership. The Company and the Operating
Partnership, jointly and severally, hereby represent and warrant to, and covenant with, the Purchasers as of the date of this Agreement
and the Closing Date, unless otherwise specified:

 

(a)              
The Company has timely filed all reports, schedules, forms, statements and other documents required to be filed by the Company
under the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein
as the “SEC Reports”), since January 1, 2018. The SEC Reports (i) as of the time they were filed (or if subsequently
amended, when amended, and as of the date hereof), complied, and comply, in all material respects with the requirements of the
Securities Act and the Exchange Act, as the case may be, and (ii) did not, at the time they were filed (or if subsequently amended
or superseded by an amendment or other filing, then, on the date of such subsequent filing), contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements made
therein, in light of the circumstances under which they were made, not misleading.

 

    	 	3	 

     

    

 

(b)              
Each of the Company and each of the subsidiaries of the Company identified on Schedule II hereto (each, a “Subsidiary”
and collectively, the “Subsidiaries”) has been duly incorporated, formed or organized and is validly existing
as a corporation, general or limited partnership or limited liability company in good standing under the laws of its respective
jurisdiction of incorporation, formation or organization with full power and authority to own its respective properties and to
conduct its respective businesses as described in the SEC Reports, and, in the case of the Company and the Operating Partnership,
to execute and deliver this Agreement and the Warrants and, in the case of the Company, to execute and deliver the Registration
Rights Agreement and the Warrant Agency Agreement (collectively, the “Transaction Documents”), as applicable,
and to consummate the transactions contemplated herein and therein and to perform its obligations under the Third Amended and Restated
Management Agreement, dated as of April 28, 2020, by and among the Company, the Operating Partnership and the Manager (the “Management
Agreement”).

 

(c)              
The Company and each of the Subsidiaries is duly qualified or licensed and in good standing in each jurisdiction in which
it conducts its businesses or in which it owns or leases real property or otherwise maintains an office and in which the failure,
individually or in the aggregate, to be so qualified or licensed would have a material adverse effect on the assets, business,
operations, earnings, prospects, properties or condition (financial or otherwise) of the Company and the Subsidiaries taken as
a whole, (any such effect or change, where the context so requires, is hereinafter called a “Material Adverse Effect”
or “Material Adverse Change”). Except as disclosed in the SEC Reports, no Subsidiary is prohibited or restricted,
directly or indirectly, from paying dividends to the Company, or from making any other distribution with respect to such Subsidiary’s
capital stock or from repaying to the Company or any other Subsidiary any amounts which may from time to time become due under
any loans or advances to such Subsidiary from the Company or such other Subsidiary, or from transferring any such Subsidiary’s
property or assets to the Company or to any other Subsidiary. Other than as disclosed in the SEC Reports, the Company and the Operating
Partnership do not own, directly or indirectly, any capital stock or other equity securities of any other corporation or any ownership
interest in any partnership, joint venture or other association.

 

(d)              
The Company and the Subsidiaries are in compliance in all material respects with all applicable laws, rules, regulations,
orders, decrees and judgments, including those relating to transactions with affiliates.

 

(e)              
Neither the Company nor any Subsidiary is in breach of or in default under (nor has any event occurred which with notice,
lapse of time, or both would constitute a breach of, or default under), (i) its respective charter, bylaws, agreement of limited
partnership, operating agreement or other similar organizational documents (the “Organizational Documents”),
(ii) the performance or observance of any obligation, agreement, covenant or condition contained in any contract, license, indenture,
mortgage, deed of trust, loan or credit agreement or other agreement or instrument to which the Company or any Subsidiary is a
party or by which any of them or their respective properties is bound, or (iii) any federal, state, local or foreign law, regulation
or rule or any decree, judgment, permit or order (each, a “Law”) applicable to the Company or any Subsidiary,
except, in the case of clauses (ii) and (iii) above, for such breaches or defaults which would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.

 

    	 	4	 

     

    

 

(f)               
The issuance and sale of the Securities, the execution, delivery and performance of the Transaction Documents, the execution
and filing of the Second Closing Articles Supplementary and the Articles of Amendment, and the consummation of the transactions
contemplated herein and thereunder (including the issuance of the Warrant Shares upon any exercise of the Warrants) will not (A)
conflict with, or result in any breach of, or constitute a default under (nor constitute any event which with notice, lapse of
time or both would constitute a breach of, or default under), (i) any provision of the Organizational Documents of the Company
or any Subsidiary, (ii) any provision of any contract, license, indenture, mortgage, deed of trust, loan or credit agreement or
other agreement or instrument to which the Company or any Subsidiary is a party or by which any of them or their respective properties
may be bound or affected, or under any Law applicable to the Company or any Subsidiary, except in the case of this clause (ii)
for such breaches or defaults which would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect; or (B) result in the creation or imposition of any lien, charge, claim or encumbrance upon any property or asset of the
Company or any Subsidiary. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common
Stock issuable pursuant to the Warrants.

 

(g)              
The consolidated financial statements, including the notes thereto, included in the SEC Reports present fairly the consolidated
financial position of the Company and the Subsidiaries as of the dates indicated and their consolidated results of operations and
changes in financial position and cash flows for the periods specified; such financial statements have been prepared in conformity
with generally accepted accounting principles as applied in the United States (“GAAP”) and on a consistent basis
during the periods involved and in accordance with Regulation S-X promulgated by the United States Securities and Exchange Commission
(the “Commission”); all disclosures contained in the SEC Reports, or incorporated by reference therein, regarding
 “non-GAAP financial measures” (as such term is defined by the rules and regulations of the Commission) comply with
Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Securities Act, to the extent applicable.

 

(h)              
All of the outstanding shares of capital stock of the Company have been duly and validly authorized and issued and are fully
paid and nonassessable. All of the outstanding shares of capital stock, partnership interests and membership interests, as the
case may be, of the Subsidiaries have been duly authorized and are validly issued, fully paid and nonassessable securities thereof
and, except as disclosed in the SEC Reports, all of the outstanding shares of capital stock, partnership interest or membership
interests, as the case may be, of the Subsidiaries are directly or indirectly owned of record and beneficially by the Company.
Except as disclosed in the SEC Reports, there are no outstanding (i) securities or obligations of the Company or any of the
Subsidiaries convertible into or exchangeable for any capital stock of the Company or any such Subsidiary, (ii) warrants,
rights or options to subscribe for or purchase from the Company or any such Subsidiary any such capital stock or any such convertible
or exchangeable securities or obligations or (iii) obligations of the Company or any such Subsidiary to issue any shares of
capital stock, any such convertible or exchangeable securities or obligation, or any such warrants, rights or options. All issued
and outstanding units of partnership interest in the Operating Partnership (“Units”) owned by the Company are
owned free and clear of any perfected security interest or any other security interests, claims, liens or encumbrances.

 

    	 	5	 

     

    

 

(i)                
The Shares have been duly and validly authorized for issuance and sale by the Company, and, when issued and delivered to
the Purchasers against payment therefor pursuant to this Agreement, will be duly and validly issued, fully paid and non-assessable
and will not be subject to any statutory and contractual preemptive rights, first refusal rights or similar rights. The Shares,
when issued and delivered against payment therefor as provided herein, will be free of any restriction upon the voting or transfer
thereof pursuant to the Company’s charter or bylaws or any agreement or other instrument to which the Company is a party
other than the restrictions on ownership and transfer set forth in the Company’s charter.

 

(j)                
The Warrant Shares have been duly and validly authorized and reserved for issuance by the Company, and, when issued upon
exercise of the Warrants in accordance with the terms of the Warrant Agency Agreement will be fully paid and nonassessable, and
the issuance of the Warrant Shares, if any, will not be subject to any statutory or contractual preemptive right, right of first
refusal or other similar rights; the Warrant Shares, when issued and delivered against payment therefor as provided in the Warrant
Agency Agreement will be free of any restriction upon the voting or transfer thereof pursuant to the Company’s charter or
bylaws or any agreement or other instrument to which the Company is a party other than the restrictions on ownership and transfer
set forth in the Company’s charter.

 

(k)              
The Company’s Articles Supplementary accepted for record by the SDAT on April 6, 2020 set forth the preferences, conversion
or other rights, restrictions, limitations as to dividends and other distributions, qualifications and terms and conditions of
redemption of the Preferred Stock (the “First Closing Articles Supplementary”). The Second Closing Articles
Supplementary classifies (i) 1,112,400 shares of authorized but unissued Preferred Stock as Series A Preferred Stock and (ii) 87,600
shares of authorized but unissued Preferred Stock as Series B Preferred Stock. The Second Closing Articles Supplementary and the
Articles of Amendment will have been filed with the SDAT, will have become effective under the Maryland General Corporation Law
(the “MGCL”) and will comply with all applicable requirements under the MGCL on or prior to the Closing Date.

 

(l)                
No approval, authorization, consent or order of or filing with any federal, state, local or foreign governmental or regulatory
commission, board, body, authority or agency is required in connection with the execution, delivery and performance of the Transaction
Documents by the Company or the Operating Partnership, as applicable, their consummation of the transactions contemplated herein
or thereunder (including the Company’s sale and delivery of the Shares and the Company’s issuance of the Warrant Shares
upon exercise of the Warrants), other than such as have been obtained, or will have been obtained at the Closing Date. No stockholder
approvals are required in connection with the issuance and sale of the Securities or the Warrant Shares upon exercise of the Warrants
in accordance with the terms of the Warrant Agency Agreement, under the rules of the New York Stock Exchange (“NYSE”).

 

    	 	6	 

     

    

 

(m)            
Each of the Transaction Documents and the Management Agreement has been duly authorized, executed and delivered by the Company
and the Operating Partnership, as applicable, and each is a legal, valid and binding agreement of the Company and the Operating
Partnership enforceable in accordance with its terms, except as may be limited by bankruptcy, insolvency, reorganization, moratorium
or similar laws affecting creditors’ rights generally, and by general equitable principles, and except to the extent that
the indemnification and contribution provisions, as applicable, contained in Section 3.1 hereof and in the Registration
Rights Agreement may be limited by federal or state securities laws and public policy considerations in respect thereof.

 

(n)              
There are no actions, suits, proceedings, inquiries or investigations pending or, to the knowledge of the Company or the
Operating Partnership, threatened against the Company or any Subsidiary or any of their respective officers and directors or to
which the properties, assets or rights of any such entity are subject, at law or in equity, before or by any federal, state, local
or foreign governmental or regulatory commission, board, body, authority, arbitral panel or agency which could result in a judgment,
decree, award or order that could reasonably be expected to have a Material Adverse Effect.

 

(o)              
Moss Adams LLP, whose reports on the consolidated financial statements of the Company and the Subsidiaries are filed with
the Commission as part of the SEC Reports, is, and was during the periods covered by its reports, an independent registered public
accounting firm as required by the Securities Act and the Exchange Act and is registered with the Public Company Accounting Oversight
Board.

 

(p)              
Each of the Company and the Subsidiaries has timely filed all tax returns required to be filed (except in any case in which
the failure to so file would not reasonably be expected to result in a Material Adverse Effect) and has paid all taxes required
to be paid and any other assessment, fine or penalty levied against it, to the extent that any of the foregoing would otherwise
be delinquent, except, in all cases, for any such tax, assessment, fine or penalty that is being contested in good faith and except
in any case in which the failure to so pay would not reasonably be expected to result in a Material Adverse Effect.

 

(q)              
The descriptions in the SEC Reports of the legal or governmental proceedings, contracts, leases and other legal documents
therein described present fairly the information required to be shown, and there are no legal or governmental proceedings, contracts,
leases, or other documents of a character required to be described in the SEC Reports or to be filed as exhibits to the SEC Reports
which are not described or filed as required. All agreements between the Company or any of the Subsidiaries and third parties expressly
referenced in the SEC Reports are legal, valid and binding obligations of the Company or one or more of the Subsidiaries, enforceable
in accordance with their respective terms, except to the extent enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium or similar laws affecting creditors’ rights generally and by general equitable principles.

 

    	 	7	 

     

    

 

(r)               
Each of the Company and the Subsidiaries maintains insurance (issued by insurers of recognized financial responsibility)
of the types and in the amounts generally deemed adequate for their respective businesses and consistent with insurance coverage
maintained by similar companies in similar businesses, including, but not limited to, insurance covering real and personal property
owned or leased by the Company and the Subsidiaries against theft, damage, destruction, acts of vandalism and all other risks customarily
insured against, all of which insurance is in full force and effect.

 

(s)               
Each of the Company and the Subsidiaries has all necessary licenses, authorizations, consents and approvals and has made
all necessary filings required under any Law and in connection with the issuance and sale of the Securities, the Warrant Shares
to be issued upon exercise of the Warrants, or the consummation by the Company and the Operating Partnership of the transactions
contemplated hereby, other than the registration of the Shares or the Warrant Shares upon exercise of the Warrants under the Securities
Act and filing the Second Closing Articles Supplementary and the Articles of Amendment with the SDAT, which has been or will be
effected. Each of the Company and the Subsidiaries has obtained all necessary licenses, authorizations, consents and approvals
from other persons required in order to conduct their respective businesses as described in the SEC Reports, except to the extent
that any failure to have any such licenses, authorizations, consents or approvals, to make any such filings or to obtain any such
authorizations, consents or approvals would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect; neither the Company nor any of the Subsidiaries is required by any applicable law to obtain accreditation or certification
from any governmental agency or authority in order to provide the products and services which it currently provides or which it
proposes to provide as set forth in the SEC Reports; neither the Company, nor any of the Subsidiaries is in violation of, in default
under, or has received any notice regarding a possible violation, default or revocation of any such license, authorization, consent
or approval or any federal, state, local or foreign law, regulation or rule or any decree, order or judgment applicable to the
Company or any of the Subsidiaries the effect of which could reasonably be expected to result in a Material Adverse Change; and
no such license, authorization, consent or approval contains a materially burdensome restriction that is not adequately disclosed
in the SEC Reports.

 

(t)                
Each of the Company and the Subsidiaries have good and marketable title in fee simple to all real property, if any, and
good title to all personal property owned by them, in each case free and clear of all liens, security interests, pledges, charges,
encumbrances, mortgages and defects, except such as are disclosed in the SEC Reports or such as do not materially and adversely
affect the value of such property and do not interfere with the use made or proposed to be made of such property by the Company
and the Subsidiaries; and any real property and buildings held under lease by the Company or any Subsidiary are held under valid,
existing and enforceable leases, with such exceptions as are disclosed in the SEC Reports or are not material and do not interfere
with the use made or proposed to be made of such property and buildings by the Company or such Subsidiary.

 

    	 	8	 

     

    

 

(u)              
The Company and each of the Subsidiaries maintain effective internal control over financial reporting (as defined under
Rules 13a-15 and 15d-15 under the Exchange Act) and a system of internal accounting controls sufficient to provide reasonable assurance
that (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability;
(iii) access to assets is permitted only in accordance with management’s general or specific authorization; (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect
to any differences; and (v) the interactive data in eXtensible Business Reporting Language incorporated by reference in the SEC
Reports fairly presents the information called for in all material respects and is prepared in accordance with the Commission’s
rules and guidelines applicable thereto; and since the date of the last audited financial statements of the Company included in
the SEC Reports, the Company is not aware of (a) any significant deficiency or material weakness in the design or operation
of its internal controls over financial reporting which are reasonably likely to adversely affect the Company’s ability to
record, process, summarize and report financial information to management and the Board of Directors, or (b) any fraud, whether
or not material, that involves management or other employees who have a significant role in the Company’s internal control
over financial reporting.

 

(v)              
The Company and each of the Subsidiaries have established and maintain disclosure controls and procedures (as such term
is defined in Rule 13a-15(e) under the Exchange Act), which (i) are designed to ensure that material information relating to the
Company, including its consolidated subsidiaries, is made known to the Company’s principal executive officer and its principal
financial officer by others within those entities, particularly during the periods in which the periodic reports required under
the Exchange Act are being prepared, and (ii) are effective in all material respects to perform the functions for which they were
established.

 

(w)            
There is and has been no failure on the part of the Company and the Subsidiaries and any of the officers and directors of
the Company and the Subsidiaries, in their capacities as such, to comply in all material respects with the provisions of the Sarbanes-Oxley
Act of 2002 and the rules and regulations promulgated thereunder and with which the Company is required to comply, including Section 402
related to loans and Sections 302 and 906 related to certifications.

 

(x)              
Commencing with its taxable year ended December 31, 2014, the Company has been organized and operated in conformity with
the requirements for qualification and taxation as a REIT under the Internal Revenue Code of 1986, as amended, including the regulations
and published interpretations thereunder (“Code”); the present and contemplated method of operation of the Company
and the Subsidiaries does and will enable the Company to continue to meet the requirements for qualification and taxation as a
REIT under the Code for its taxable year ending December 31, 2020, and thereafter and all statements regarding the Company’s
qualification and taxation as a REIT and descriptions of the Company’s organization and method of operation (inasmuch as
they relate to the Company’s qualification and taxation as a REIT) set forth in the SEC Reports are accurate and fair summaries
of the legal or tax matters described therein in all material respects. The Operating Partnership is treated as a disregarded entity,
and not as an association taxable as a corporation, for U.S. federal income tax purposes. The Company has not been, is not and
will use commercially reasonable efforts not to be during any time that the Shares or Warrant Shares are outstanding a “United
States real property holding corporation” within the meaning of Section 897(c) of the Code.

 

    	 	9	 

     

    

 

(y)              
The Company and each Subsidiary owns or possesses adequate licenses or other rights to use all patents, trademarks, service
marks, trade names, copyrights, software and design licenses, trade secrets, manufacturing processes, other intangible property
rights and know-how (collectively “Intangibles”) necessary to entitle the Company and each Subsidiary to conduct
its business as described in the SEC Reports, and neither the Company nor any Subsidiary has received notice of infringement of
or conflict with (and neither the Company nor any Subsidiary knows of any such infringement of or conflict with) asserted rights
of others with respect to any Intangibles which would reasonably be expected to have a Material Adverse Effect.

 

(z)              
Except for the financial advisory fee to Piper Sandler & Co., no brokerage or finder’s fees or commissions are
or will be payable by the Company or any of its subsidiaries to any broker, financial advisor or consultant, finder, placement
agent, investment banker, bank or other person with respect to the transactions contemplated herein.

 

(aa)           
Neither the Company nor any of its Subsidiaries is, and after giving effect to the offering and sale of the Securities or
the issuance of any Warrant Shares following exercise of the Warrants will be, an “investment company” or an entity
 “controlled” by an “investment company”, as such terms are defined in the Investment Company Act of 1940,
as amended.

 

(bb)          
The Securities conform in all material respects to the descriptions thereof contained in the SEC Reports, this Agreement,
the Warrant Agency Agreement and the First Closing Articles Supplementary, the Second Closing Articles Supplementary and the Articles
of Amendment.

 

(cc)           
Except as disclosed in the SEC Reports, there are no persons with registration or other similar rights to have any equity
or debt securities, including securities which are convertible into or exchangeable for equity securities, registered pursuant
to any registration statement or otherwise registered by the Company or the Operating Partnership under the Securities Act, all
of which registration or similar rights are fairly summarized in the SEC Reports.

 

    	 	10	 

     

    

 

(dd)          
Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, neither
the Company nor the Subsidiaries is in violation of any federal, state, local or foreign statute, law, rule, regulation, ordinance,
code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative
order, consent, decree or judgment, relating to pollution or protection of human health, the environment (including, without limitation,
ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and
regulations relating to the release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum
or petroleum products, asbestos-containing materials or mold (collectively, “Hazardous Materials”) or to the
manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively,
 “Environmental Laws”). Each of the Company and the Subsidiaries has all permits, authorizations and approvals
required under any applicable Environmental Laws and are each in compliance with their requirements. There are no pending or, to
the knowledge of the Company or the Operating Partnership, threatened administrative, regulatory or judicial actions, suits, demands,
demand letters, claims, liens, notices of noncompliance or violation, investigations or proceedings relating to any Environmental
Law against the Company or the Subsidiaries. To the knowledge of the Company or the Operating Partnership, there are no events
or circumstances that would reasonably be expected to form the basis of an order for clean-up or remediation, or an action, suit
or proceeding by any private party or governmental body or agency, against or affecting the Company or the Subsidiaries relating
to Hazardous Materials or any Environmental Laws.

 

(ee)           
Neither the Company nor any Subsidiary is in violation of or has received notice of any violation with respect to any federal
or state law relating to discrimination in the hiring, promotion or pay of employees, nor any applicable federal or state wages
and hours law, nor any state law precluding the denial of credit due to the neighborhood in which a property is situated, the violation
of any of which would reasonably be expected to have a Material Adverse Effect.

 

(ff)             
The Company and each of the Subsidiaries are in compliance in all material respects with all presently applicable provisions
of the Employee Retirement Income Security Act of 1974, as amended, including the regulations and published interpretations thereunder
(“ERISA”); no “reportable event” (as defined in ERISA) has occurred with respect to any “pension
plan” (as defined in ERISA) for which the Company or any of the Subsidiaries would have any liability; the Company and each
of the Subsidiaries have not incurred and do not expect to incur liability under (i) Title IV of ERISA with respect to termination
of, or withdrawal from, any “pension plan” or (ii) Section 412 or 4971 of the Code; and each “pension plan”
for which the Company and each of its Subsidiaries would have any liability that is intended to be qualified under Section 401(a)
of the Code is so qualified in all material respects and nothing has occurred, whether by action or by failure to act, which would
cause the loss of such qualification.

 

(gg)          
Except as otherwise disclosed in the SEC Reports, there are no outstanding loans, extensions of credit or advances or guarantees
of indebtedness by the Company or any of the Subsidiaries to or for the benefit of any of the officers or directors of the Company
or any of the Subsidiaries or any of the members of the families of any of them.

 

    	 	11	 

     

    

 

(hh)          
All securities issued by the Company, any of the Subsidiaries or any trusts established by the Company or any Subsidiary,
have been or will be issued and sold in compliance with (i) all applicable federal and state securities laws, (ii) the laws of
the applicable jurisdiction of incorporation of the issuing entity and, (iii) to the extent applicable to the issuing entity, the
requirements of the NYSE.

 

(ii)             
No relationship, direct or indirect, exists between or among the Company or any of the Subsidiaries on the one hand, and
the directors, officers, stockholders, customers or suppliers of the Company or any of the Subsidiaries on the other hand, which
is required by the Securities Act to be described in the SEC Reports, which is not so described.

 

(jj)             
There are no existing or, to the knowledge of the Company or the Operating Partnership, threatened labor disputes with the
employees of the Company or any of the Subsidiaries which would reasonably be expected to have, individually or in the aggregate,
a Material Adverse Effect; no labor dispute exists between any officers of the Company or the Operating Partnership (each, a “Company-Focused
Professional”), on the one hand, and the employer of each such individual on the other hand.

 

(kk)          
Neither the Company nor the Operating Partnership nor, to the best of the Company’s or the Operating Partnership’s
knowledge, any employer of any Company-Focused Professional has been notified that any such Company-Focused Professional plans
to terminate his or her employment with his or her employer; neither the Company nor the Operating Partnership nor, to the best
of the Company’s knowledge, any Company-Focused Professional is subject to any noncompete, nondisclosure, confidentiality,
employment, consulting or similar agreement that would be violated by the present or proposed business activities of the Company,
the Operating Partnership or the Manager as described in the SEC Reports.

 

(ll)             
Neither the Company nor any of the Subsidiaries, nor any officer or director purporting to act on behalf of the Company
or any of the Subsidiaries, nor the Manager or its affiliates acting on behalf of the Company or any of the Subsidiaries, has at
any time (i) made any unlawful contributions to any candidate for political office, or failed to disclose fully any such contributions,
in violation of law, (ii) made any payment to any state, federal or foreign governmental officer or official, or other person charged
with similar public or quasi-public duties, other than payments required or allowed by applicable law, (iii) made any payment outside
the ordinary course of business to any investment officer or loan broker or person charged with similar duties of any entity to
which the Company or any of the Subsidiaries sells or from which the Company or any of the Subsidiaries buys loans or servicing
arrangements for the purpose of influencing such agent, officer, broker or person to buy loans or servicing arrangements from or
sell loans to the Company or any of the Subsidiaries, or (iv) engaged in any transactions, maintained any bank account or used
any corporate funds except for transactions, bank accounts and funds which have been and are reflected in the normally maintained
books and records of the Company and the Subsidiaries; neither the Company nor any of the Subsidiaries or, to the knowledge of
the Company or the Operating Partnership, any director, officer, agent, employee or affiliate of such entities is aware of or has
taken any action, directly or indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act
of 1977, as amended, and the rules and regulations thereunder (the “FCPA”), including, without limitation, making
use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise
to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of
anything of value to any “foreign official” (as such term is defined in the FCPA) or any foreign political party or
official thereof or any candidate for foreign political office, in contravention of the FCPA and the Company and the Subsidiaries
and, to the knowledge of the Company and the Operating Partnership, their affiliates have conducted their businesses in compliance
with the FCPA.

 

    	 	12	 

     

    

 

(mm)     
Neither the Company nor the Subsidiaries, nor, to the Company’s or the Operating Partnership’s knowledge, any
employee or agent of the Company or the Subsidiaries, has made any payment of funds of the Company or the Subsidiaries or received
or retained any funds in violation of any law, rule or regulation, including without limitation, the “know your customer”
and anti-money laundering laws of any jurisdiction (collectively, the “Money Laundering Laws”) and no action,
suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
the Subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or the Operating Partnership,
threatened.

 

(nn)          
Neither the Company nor the Subsidiaries, nor, to the knowledge of the Company or the Operating Partnership, any director,
officer, agent, employee or affiliate of the Company or the Subsidiaries, nor the Manager or its affiliates acting on behalf of
the Company or the Operating Partnership, is currently subject to any U.S. sanctions administered by the United States Government,
including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury the United Nations Security
Council, the European Union, Her Majesty’s Treasury, or other relevant sanctions authority (collectively, “Sanctions”);
and the Company will not directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute
or otherwise make available such proceeds to any Subsidiary, joint venture partner or other person or entity, for the purpose of
financing the activities of any person currently subject of Sanctions or in any other manner that will result in a violation by
any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions.
For the past five years, the Company and the Subsidiaries have not knowingly engaged in and are not now knowingly engaged in any
dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of
Sanctions or with any country subject to Sanctions.

 

(oo)          
Subsequent to the respective dates as of which information is given in the SEC Reports, and except as may be otherwise stated
in such documents, there has not been (A) any Material Adverse Change or any development that could reasonably be expected
to result in a Material Adverse Change, whether or not arising in the ordinary course of business, (B) any transaction that
is material to the Company and the Subsidiaries taken as a whole, contemplated or entered into by the Company or any of the Subsidiaries,
(C) any obligation, contingent or otherwise, directly or indirectly incurred by the Company or any Subsidiary that is material
to the Company and the Subsidiaries taken as a whole, or (D) any dividend or distribution of any kind declared, paid or made
by the Company on any class of its capital stock or by the Operating Partnership on its Units.

 

    	 	13	 

     

    

 

2.2             
Representations and Warranties of the Manager. The Manager hereby makes the following representations and warranties
to the Purchasers as of the date hereof and the Closing Date, unless otherwise specified:

 

(a)              
As of the date of this Agreement, the Manager has no plan or intention to materially alter its investment policy, investment
allocation policy or exclusivity policy with respect to the Company as described in the SEC Reports.

 

(b)              
The Manager has been duly organized and is validly existing as a limited liability company in good standing under the laws
of the state of Delaware with full power and authority to own its respective properties and to conduct its respective businesses
as described in the SEC Reports, and to execute and deliver the Transaction Documents, as applicable, and to consummate the transactions
contemplated herein and therein.

 

(c)              
The Manager is duly qualified or licensed and in good standing in each jurisdiction in which it conducts its businesses
or in which it owns or leases real property or otherwise maintains an office and in which the failure, individually or in the aggregate,
to be so qualified or licensed would have a material adverse effect on the assets, business, operations, earnings, prospects, properties
or condition (financial or otherwise) of the Manager (any such effect or change, where the context so requires, is hereinafter
called a “Manager Material Adverse Effect” or “Manager Material Adverse Change”).

 

(d)              
The Manager is in compliance in all material respects with all applicable laws, rules, regulations, orders, decrees and
judgments, including those relating to transactions with affiliates.

 

(e)              
The Manager is not in breach of or in default under (nor has any event occurred which with notice, lapse of time, or both
would constitute a breach of, or default under), (i) its operating agreement, bylaws or other similar organizational documents
(the “Manager Organizational Documents”), (ii) the performance or observance of any obligation, agreement, covenant
or condition contained in any license, indenture, mortgage, deed of trust, loan or credit agreement or other agreement or instrument
to which the Manager is a party or by which any of it or its respective properties is bound (together with the Manager Organizational
Documents, the “Manager Agreements”), or (iii) any Law applicable to the Manager, except, in the case of clauses
(ii) and (iii) above, for such breaches or defaults which would not, individually or in the aggregate, reasonably be expected to
have a Manager Material Adverse Effect.

 

(f)               
The execution, delivery and performance of the Transaction Documents, as applicable, and consummation of the transactions
contemplated herein and therein, and compliance by the Manager with its obligations hereunder and the Management Agreement will
not (A) conflict with, or result in any breach of, or constitute a default under (nor constitute any event which with notice, lapse
of time, or both would constitute a breach of, or default under), (i) any provision of the Manager Organizational Documents, or
(ii) any provision of any contract, license, indenture, mortgage, deed of trust, loan or credit agreement or other agreement or
instrument to which the Manager is a party or by which any of it or its respective properties may be bound or affected, or under
any Law applicable to the Manager, except in the case of this clause (ii) for such breaches or defaults which would not, individually
or in the aggregate, reasonably be expected to have a Manager Material Adverse Effect; or (B) result in the creation or imposition
of any lien, charge, claim or encumbrance upon any property or asset of the Manager.

 

    	 	14	 

     

    

 

(g)              
Each of the Transaction Documents, as applicable, and the Management Agreement has been duly authorized, executed and delivered
by the Manager and each is a legal, valid and binding agreement of the Manager enforceable in accordance with its terms, except
as may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally,
and by general equitable principles, and except to the extent that the indemnification and contribution provisions, as applicable,
contained in Section 3.1 hereof and in the Registration Rights Agreement may be limited by federal or state securities laws
and public policy considerations in respect thereof.

 

(h)              
The Manager has all necessary licenses, authorizations, consents and approvals and has made all necessary filings required
under any Law, and has obtained all necessary authorizations, consents and approvals from other persons, required in order to conduct
its business as described in the SEC Reports, except to the extent that any failure to have any such licenses, authorizations,
consents or approvals, to make any such filings or to obtain any such authorizations, consents or approvals would not, individually
or in the aggregate, reasonably be expected to have a Manager Material Adverse Effect; the Manager is not required by any applicable
law to obtain accreditation or certification from any governmental agency or authority in order to provide the products and services
which it currently provides or which it proposes to provide as set forth in the SEC Reports; the Manager is not in violation of,
in default under, or has received any notice regarding a possible violation, default or revocation of any such license, authorization,
consent or approval or any federal, state, local or foreign law, regulation or rule or any decree, order or judgment applicable
to the Manager the effect of which could reasonably be expected to result in a Manager Material Adverse Change; and no such license,
authorization, consent or approval contains a materially burdensome restriction that is not adequately disclosed in the SEC Reports.

 

(i)                
None of the Manager or any of its respective directors, officers, representatives or affiliates has taken, nor will take,
directly or indirectly, any action which is designed to or which has constituted or which might reasonably be expected to cause
or result in stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the
Securities or the Warrant Shares to be issued upon exercise of the Warrants, or to result in a violation at Regulation M under
the Exchange Act.

 

(j)                
The Manager maintains a system of internal accounting controls sufficient to provide reasonable assurance that (i) the transactions
that may be effectuated by it on behalf of the Company pursuant to its duties set forth in the Management Agreement will be executed
in accordance with management’s general or specific authorization and (ii) access to the Company’s assets is permitted
only in accordance with its management’s general or specific authorization.

 

    	 	15	 

     

    

 

(k)              
There are no actions, suits, proceedings, inquiries or investigations pending or, to the knowledge of the Manager, threatened
against the Manager or any of its respective officers and directors or to which the properties, assets or rights of any such entity
are subject, at law or in equity, before or by any federal, state, local or foreign governmental or regulatory commission, board,
body, authority, arbitral panel or agency which could result in a judgment, decree, award or order reasonably likely to result
in a Manager Material Adverse Effect.

 

(l)                
The Manager is not required to register as an investment adviser with the Commission under the Investment Advisers Act of
1940, as amended (the “Advisers Act”), and is not prohibited by the Advisers Act, or the rules and regulations
thereunder, from performing its obligations under the Management Agreement as described in the SEC Reports and the Management Agreement.

 

2.3             
Representations, Warranties and Covenants of the Purchasers. Each of the Purchasers, severally but not jointly, represent
and warrant to, and covenant with, the Company and the Operating Partnership, as of the date of this Agreement and the Closing
Date, that:

 

(a)              
Experience. (i) Such Purchaser is knowledgeable, sophisticated and experienced in financial and business matters
in making, and is qualified to make, decisions with respect to investments in shares representing an investment decision like that
involved in the purchase of the Securities, including investments in securities issued by the Company and comparable entities and
has the ability to bear the economic risks of an investment in the Securities; (ii) such Purchaser is acquiring the Securities
in the ordinary course of its business and for its own account for investment only and with no present intention of distributing
any Securities or any arrangement or understanding with any other persons regarding the distribution of any Securities (this representation
and warranty does not limit such Purchaser’s right to sell in compliance with the Securities Act and the rules and regulations
promulgated under the Exchange Act and the Securities Act (together, the “Rules and Regulations”)); (iii) such
Purchaser will not, directly or indirectly, offer, sell, pledge, transfer or otherwise dispose of (or solicit any offers to buy,
purchase or otherwise acquire or take a pledge of) any Securities, nor will such Purchaser engage in any Short Sale (as defined
below) that results in a disposition of any Securities by such Purchaser, except in compliance with the Securities Act and the
Rules and Regulations and any applicable state securities laws; (iv) at the Closing Date, such Purchaser has completed or caused
to be completed the Resale Registration Statement Questionnaire attached hereto as part of Appendix I, for use in preparation
of the registration statement to be filed pursuant to the Registration Rights Agreement (the “Resale Registration Statement”),
and the answers thereto are true and correct in all material respects as of the Closing Date and such Purchaser will notify the
Company immediately of any material change in any such information provided in the Resale Registration Statement Questionnaire
until such time as such Purchaser has sold all of its Warrant Shares, if any, or until the Company is no longer required to keep
the Resale Registration Statement effective; provided, that such Purchaser shall not be required to update the number of
securities held by such Purchaser; (v) any other written information furnished to the Company by or on behalf of such Purchaser
expressly for inclusion in the Resale Registration Statement will be true and correct in all material respects as of the date such
other written information is provided and such Purchaser will notify the Company immediately of any material change in any such
other written information until such time as such Purchaser has sold all of its Warrant Shares, if any, or until the Company is
no longer required to keep the Resale Registration Statement effective; and (vi) such Purchaser has had an opportunity to discuss
this investment with representatives of the Company and ask questions of them.

 

    	 	16	 

     

    

 

(b)              
Institutional Accredited Investor. Such Purchaser is an institutional accredited investor (as defined in Rule 501(a)
of Regulation D under the Securities Act).

 

(c)              
Reliance on Exemptions. Such Purchaser understands that the Securities are being offered and sold to it in reliance
upon specific exemptions from the registration requirements of the Securities Act, the Rules and Regulations and state securities
laws and that the Company is relying upon the truth and accuracy of, and such Purchaser’s compliance with, the representations,
warranties, agreements, acknowledgments and understandings of such Purchaser set forth herein in order to determine the availability
of such exemptions and the eligibility of such Purchaser to acquire the Securities.

 

(d)              
No Reliance. In making a decision to purchase the Securities, such Purchaser: (i) is capable of evaluating investment
risks independently, both in general and with regard to all transactions and investment strategies involving securities; (ii) will
exercise independent judgment in evaluating the recommendations of any broker-dealer or its associated persons; and (iii) confirms
that it has undertaken an independent analysis of the merits and risks of an investment in the Company, based on such Purchaser’s
own financial circumstances.

 

(e)              
Confidentiality. Such Purchaser understands that the existence and nature of all conversations regarding the Company
and this offering (such information, together with the Transaction Documents and the information described in the following sentence,
the “Confidential Information”) must be kept strictly confidential. In addition to the above, such Purchaser
shall maintain in confidence the receipt and content of any notice of a Suspension (as defined in Section 2.3(j) below).
Notwithstanding the foregoing, any Purchaser may disclose Confidential Information: (i) to potential purchasers of equity securities
of such Purchaser or its Affiliates, provided that the recipient has agreed to abide and be bound by the provisions hereof
or is otherwise bound by confidentiality obligations; (ii) to such Purchaser’s direct or indirect limited partners, members
and stockholders and existing and prospective investors in connection with their reporting, marketing and fundraising activities
and their respective tax, legal and accounting and other advisors that need to know such information, provided, in each
case, that the recipient has agreed to abide and be bound by the provisions hereof or is otherwise bound by confidentiality obligations;
(iii) as is required to be disclosed by order of a court of competent jurisdiction, administrative body or governmental body, or
by subpoena, summons or legal process, or by law, rule or regulation, provided that, to the extent permitted by law, such
Purchaser required to make such disclosure shall provide to the Company prompt notice of such disclosure, other than filings made
publicly with the Commission, which shall be deemed to have been provided to the Company by virtue of such filing; and (iv) to
any person in connection with the enforcement of the terms of this Agreement or the other agreements contemplated hereby. Nothing
herein shall limit disclosure of information by a Purchaser or its Affiliates in connection with a routine audit or examination
by, or a blanket document request from, a regulatory or self-regulatory authority, bank examiner or auditor with authority over
such Purchaser or its Affiliates that does not specifically reference the Company or the Confidential Information. For purposes
of this Section 2.3(e), “Confidential Information” shall not include any information that: (i) is or becomes generally
available to the public other than as a result of a disclosure by such Purchaser or any of its Affiliates or representatives in
breach of this Section 2.3(e), (ii) was in such Purchaser’s possession prior to being furnished to such Purchaser by or on
behalf of the Company, or (iii) is disclosed to a Purchaser or its Affiliates following the date hereof by a person that is not
bound by an obligation or duty of confidentiality to the Company or any of its Subsidiaries to the knowledge of such Purchaser
or its Affiliates after reasonable inquiry.

 

    	 	17	 

     

    

 

(f)               
Investment Decision. Such Purchaser understands that nothing in this Agreement or any other materials presented to
such Purchaser in connection with the purchase and sale of the Securities constitutes legal, tax or investment advice. Such Purchaser
has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection
with its purchase of the Securities.

 

(g)              
Risk of Loss. Such Purchaser understands that its investment in the Securities involves a significant degree of risk,
including a risk of total loss of such Purchaser’s investment, and such Purchaser has full cognizance of and understands
all of the risk factors related to such Purchaser’s purchase of the Securities, including the risk factors set forth in the
SEC Reports.

 

(h)              
Legends. Such Purchaser understands that, until such time as the Securities and any Warrant Shares may be sold pursuant
to Rule 144 under the Securities Act without any restriction as to the number of securities as of a particular date that can then
be immediately sold and except if and to the extent otherwise provided below in this Section 2.3, the Securities and
any Warrant Shares will bear a restrictive legend in substantially the following form:

 

“THE SHARES
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS
OF ANY STATE OR OTHER JURISDICTION. THE SHARES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) PURSUANT TO
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OR (2) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE STATE SECURITIES LAWS AND THE SECURITIES LAWS OF OTHER JURISDICTIONS, AND IN
THE CASE OF A TRANSACTION EXEMPT FROM REGISTRATION, UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY
TO IT THAT SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT AND SUCH OTHER APPLICABLE LAWS.”

 

    	 	18	 

     

    

 

Further, such
Purchaser understands that any Securities or Warrant Shares held by Flexpoint Special Assets Fund, L.P., an affiliate of the Company,
will bear an additional restrictive legend in substantially the following form:

 

“THE SHARES
REPRESENTED BY THIS CERTIFICATE ARE OWNED BY A PERSON OR PERSONS WHO MAY BE CONSIDERED AN AFFILIATE FOR PURPOSES OF RULE 144 UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). NO OFFER, SALE, TRANSFER OR ASSIGNMENT OF THESE SHARES OR ANY INTEREST
THEREIN MAY BE MADE UNLESS THE ISSUER HAS RECEIVED AN OPINION OF COUNSEL SATISFACTORY TO IT THAT THE SHARES MAY BE SOLD PURSUANT
TO RULE 144 UNDER THE ACT OR ANOTHER APPLICABLE EXEMPTION FROM REGISTRATION UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.”

 

The Shares
and Warrant Shares shall not be required to contain any legend (including the legends set forth above in this Section 2.3
hereof) while a registration statement (including the Resale Registration Statement) covering the resale of such Shares and Warrant
Shares is effective under the Securities Act.

 

The Company
shall cause its counsel to issue a legal opinion to the Transfer Agent if required by the Transfer Agent to effect the removal
of the legends hereunder, provided that such legends are not required pursuant to the foregoing provisions of this paragraph.

 

(i)                
Stop Transfer. When issued, the Securities purchased hereunder and any Warrant Shares will be subject to a stop transfer
order with the Transfer Agent that restricts the transfer of such shares except upon receipt by the Transfer Agent, in accordance
with the provisions of Section 2.3(j) below, of a written confirmation from such Purchaser to the effect that such Purchaser
has satisfied its prospectus delivery requirements or upon receipt by the Transfer Agent of written instructions from the Company
authorizing such transfer.

 

(j)                
Public Sale or Distribution. Such Purchaser hereby covenants with the Company not to make any sale of the Shares
and Warrant Shares under the Resale Registration Statement without complying with the provisions of this Agreement and without
effectively causing the prospectus delivery requirement under the Securities Act to be satisfied (whether physically or through
compliance with Rule 172 under the Securities Act or any similar rule). Such Purchaser acknowledges that there may occasionally
be times when the Company must suspend the use of the prospectus (the “Prospectus”) forming a part of the Resale
Registration Statement (a “Suspension”) until such time as an amendment to the Resale Registration Statement
has been filed by the Company and declared effective by the Commission, or until such time as the Company has filed an appropriate
report with the Commission pursuant to the Exchange Act. Without the Company’s prior written consent, such Purchaser shall
not use any written materials to offer the Shares or Warrant Shares for resale other than the Prospectus, including any “free
writing prospectus” as defined in Rule 405 under the Securities Act. Such Purchaser covenants that it will not sell any Shares
or Warrant Shares pursuant to said Prospectus during the period commencing at the time when the Company gives such Purchaser written
notice of the Suspension of the use of said Prospectus and ending at the time when the Company gives such Purchaser written notice
that such Purchaser may thereafter effect sales pursuant to said Prospectus. Notwithstanding the foregoing, the Company agrees
that no Suspension shall be for a period of longer than 90 consecutive days, and no Suspension shall be for a period longer than
120 days in the aggregate in any 360-day period. Such Purchaser further covenants to notify the Company promptly of the sale of
all of its Shares or Warrant Shares. At any time that such Purchaser is an affiliate of the Company, any resale of the Shares or
Warrant Shares that purports to be effected under Rule 144 shall comply with all of the requirements of such rule, including the
 “manner of sale” requirements set forth in Rule 144(f).

 

    	 	19	 

     

    

 

(k)              
Authority; Validity; Enforcement. Such Purchaser further represents and warrants to, and covenants with, the Company
that (i) such Purchaser has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions
contemplated hereby and has taken all necessary action to authorize the execution, delivery and performance of this Agreement,
(ii) the making and performance of this Agreement by such Purchaser and the consummation of the transactions herein contemplated
will not violate any applicable provision of the organizational documents of such Purchaser or conflict with, result in the breach
or violation of, or constitute, either by itself or upon notice or the passage of time or both, a default under any material agreement,
mortgage, deed of trust, lease, franchise, license, indenture, permit or other instrument to which such Purchaser is a party or,
any statute or any authorization, judgment, decree, order, rule or regulation of any court or any regulatory body, administrative
agency or other governmental agency or body applicable to such Purchaser, (iii) no consent, approval, authorization or other order
of any court, regulatory body, administrative agency or other governmental agency or body is required on the part of such Purchaser
for the execution and delivery of this Agreement or the consummation of the transactions contemplated by this Agreement, (iv) upon
the execution and delivery of this Agreement, this Agreement shall constitute a legal, valid and binding obligation of such Purchaser,
enforceable in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium or other laws of general application relating to or the enforcement of creditor’s rights and the application of
equitable principles relating to the availability of remedies, and except as rights to indemnity or contribution, including, but
not limited to, the indemnification and contribution provisions, as applicable, contained in Section 3.1 hereof and within
the Registration Rights Agreement may be limited by federal or state securities laws or the public policy underlying such laws
and (v) there is not in effect any order enjoining or restraining such Purchaser from entering into or engaging in any of the transactions
contemplated by this Agreement.

 

(l)                
Certain Transactions. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor
has any person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any “short
sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (“Short Sales”), of the securities
of the Company during the period commencing as of December 31, 2019 and ending immediately prior to the execution hereof.

 

    	 	20	 

     

    

 

(m)            
Access to Information. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents
(including all exhibits and schedules thereto), the SEC Reports and has been afforded (i) the opportunity to ask such questions
as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions
of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the
Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable
it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can
acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.

 

(n)              
Material Non-Public Information. Each Purchaser hereby acknowledges that it has not received from the Company or
otherwise any material non-public information about the Company. Each Purchaser further acknowledges that it and its representatives
are aware that the U.S. securities laws prohibit any person who has material non-public information about an issuer from purchasing
or selling, directly or indirectly, securities of such issuer (including entering into hedge transactions involving such securities),
or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such
person is likely to purchase or sell such securities.

 

(o)              
Tax Matters. Each Purchaser represents that either (i) such Purchaser is a “United States person” within
the meaning of Section 7701(a)(30) of the Code, or (ii) taking into account ownership of the Warrant Shares and any common stock
of the Company owned by such Holder of the Warrants, such Purchaser would not be a “10-percent shareholder” of the
Company within the meaning of Section 871(h)(3)(B) of the Code. The parties agree that ownership of Shares shall not be taken
into account in making the determination under Section 2.3(o)(ii).

 

(p)              
Outstanding Option. Each Purchaser hereby acknowledges and consents to the right of the existing holders of the outstanding
Series A Preferred Stock and Series B Preferred Stock to exercise their option to purchase up to 800,000 shares of Preferred Stock
(collectively, the “Option Shares”) at the liquidation preference of $25.00 per share for an aggregate purchase
price of up to $20,000,000 and be issued warrants corresponding to the number of exercised Option Shares of each series of Preferred
Stock.

 

    	 	21	 

     

    

 

ARTICLE
III.

INDEMNIFICATION

 

3.1             
Indemnification.

 

(a)              
For the purpose of this Section 3.1 and Section 4.9: the term “Purchaser/Affiliate” shall mean
any affiliate of any Purchaser, including a transferee who is an affiliate of any Purchaser, and any person who controls any Purchaser
or any affiliate of any Purchaser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act.

 

(b)              
The Company and the Operating Partnership, jointly and severally, agree to indemnify and hold harmless each Purchaser and
each Purchaser/Affiliate, against any losses, claims, actions, damages, liabilities or expenses (including the reasonable cost
of investigation and any legal, attorneys or other fees or expenses reasonably incurred by such party in connection with investigating
or defending any action or claim) (collectively, “Losses”), joint or several, to which any Purchaser or Purchaser/Affiliates
may become subject or incur, under the Securities Act, the Exchange Act, or any other federal or state statutory law or regulation,
or at common law or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent
of the Company, which consent shall not be unreasonably withheld or delayed), insofar as any such Losses (or actions in respect
thereof as contemplated below) (i) arise out of or are based in whole or in part on any breach in the representations, warranties
and covenants of the Company, the Operating Partnership or the Manager contained in this Agreement, or any failure of the Company
to perform its obligations hereunder or under law; and (ii) arise out of or are based in whole or in part on any application or
other document, or any amendment or supplement thereto, executed by the Company, the Operating Partnership or the Manager or based
upon written information furnished by or on behalf of the Company filed in any jurisdiction (domestic or foreign) in order to qualify
the Securities or the Warrant Shares issuable upon exercise of the Warrants under the securities or blue sky laws thereof or filed
with the Commission or any securities association or securities exchange, and will promptly reimburse each Purchaser and each Purchaser/Affiliate
for any legal and other expenses as such expenses are reasonably incurred by such Purchaser or such Purchaser/Affiliate in connection
with investigating, defending or preparing to defend, settling, compromising or paying any such Losses; provided, however,
that neither the Company nor the Operating Partnership will be liable for amounts paid in settlement of any such loss, claim, damage,
liability or action if such settlement is effected without the written consent of the Company, which consent shall not be unreasonably
withheld or delayed, and neither the Company nor the Operating Partnership will be liable in any such case to the extent that any
such Losses arise out of or are based upon (A) the failure of any Purchaser to comply with the covenants and agreements contained
in Section 2.3 hereof; or (B) the breach in the representations or warranties made by any Purchaser herein. The indemnity
agreement set forth in this Section 3.1(b) shall be in addition to any liability to which the Company, the Operating Partnership
or the Manager may otherwise have.

 

(c)              
Each Purchaser, severally and not jointly, will indemnify and hold harmless the Company, each of its directors, each person,
if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, and
the Operating Partnership against any Losses to which the Company, each of its directors, each controlling person or the Operating
Partnership may become subject or incur, under the Securities Act, the Exchange Act, or any other federal or state statutory law
or regulation, or at common law or otherwise (including in settlement of any litigation) insofar as such Losses (or actions in
respect thereof as contemplated below) arise out of or are based upon (i) the failure of such Purchaser to comply with the
covenants and agreements contained in Section 2.3 hereof; or (ii) any breach in the representations or warranties made
by such Purchaser herein.

 

    	 	22	 

     

    

 

(d)              
Promptly after receipt by an indemnified party under this Section 3.1 of notice of the threat or commencement of
any action, such indemnified party will, if a claim in respect thereof is to be made against an indemnifying party under this Section
3.1 promptly notify each such indemnifying party in writing thereof, but the failure or delay to notify such indemnifying parties
will not relieve such indemnifying parties from any liability that they may have to any indemnified party under the indemnity agreement
contained in this Section 3.1, except to the extent that its ability to defend is actually impaired by such failure or delay.
In case any such action is brought against any indemnified party and such indemnified party seeks or intends to seek indemnity
from any indemnifying party, the indemnifying party will be entitled to participate in, and, to the extent that it may wish, jointly
with all other indemnifying parties similarly notified, to assume the defense thereof with counsel reasonably satisfactory to such
indemnified party; provided, however, if the defendants in any such action include both the indemnified party, and
the indemnifying party and the indemnified party shall have reasonably concluded, based on the advice of counsel reasonably satisfactory
to the indemnifying party, that there may be a conflict of interest between the positions of the indemnifying party and the indemnified
party in conducting the defense of any such action or that there may be legal defenses available to it and/or other indemnified
parties that are different from or additional to those available to the indemnifying party (in which case the Company shall not
have the right to direct the defense of such action on behalf of the indemnified party or parties or the named parties in any such
proceeding (including any impleaded parties included by the Company and the indemnified person)), the indemnified party or parties
shall have the right to select separate counsel to assume such legal defenses and to otherwise participate in the defense of such
action on behalf of such indemnified party or parties. Upon receipt of notice from the indemnifying party to such indemnified party
of its election to assume the defense of such action and approval by the indemnified party of counsel, the indemnifying party will
not be liable to such indemnified party under this Section 3.1 for any legal or other expenses subsequently incurred by
such indemnified party in connection with the defense thereof unless (i) the indemnified party shall have employed such counsel
in connection with the assumption of legal defenses in accordance with the proviso to the preceding sentence (it being understood,
however, that the indemnifying party shall not be liable for the expenses of more than one separate counsel, reasonably satisfactory
to such indemnifying party, representing all of the indemnified parties who are parties to any one action or series of related
actions in the same jurisdiction (other than local counsel in any such jurisdiction)) or (ii) the indemnifying party shall not
have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified party within a reasonable time
after notice of commencement of action, in each of which cases the reasonable fees and expenses of counsel shall be at the expense
of the indemnifying party. In no event shall any indemnifying party be liable for any settlement or in respect of any amounts paid
in settlement of any claim, action or proceeding unless the indemnifying party shall have approved in writing the terms of such
settlement; provided, however, that such consent shall not be unreasonably withheld or delayed. No indemnifying party
shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened claim, action
or proceeding in respect of which any indemnified party is or could have been a party and indemnification could have been sought
hereunder by such indemnified party from all Losses that are the subject matter of such claim, action or proceeding, unless such
settlement (x) includes an unconditional release of such indemnified party, in form and substance reasonably satisfactory to such
indemnified party, from all liability on claims that are the subject matter of the subject claim, action or proceeding and (y)
does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any indemnified
party.

 

    	 	23	 

     

    

 

ARTICLE
IV.

MISCELLANEOUS

 

4.1             
Consent of Holders of Outstanding Preferred Stock. Each of the holders of the outstanding shares of Series A Preferred
Stock and Series B Preferred Stock hereby irrevocably waives the preemptive right set forth in Section 10 of the First Closing
Articles Supplementary and all other rights set forth therein with respect to the sale and issuance of the Securities as set forth
in this Agreement. Further, each of the holders of the outstanding shares of Series A Preferred Stock and Series B Preferred Stock
hereby consent to and approve the Amendment and the filing of the Second Closing Articles Supplementary and the Articles of Amendment
with the SDAT.

 

4.2             
Fees and Expenses. Except as set forth in this Agreement, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation,
any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered
by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of the Securities and any Warrant
Shares upon the exercise of the Warrants to the Purchasers.

 

4.3             
Tax Treatment for the Warrants. Unless otherwise required by applicable law, the Company and each of the Purchasers
agree to treat each Warrant as a debt instrument for U.S. federal income tax purposes with stated interest rate of 0%, maturity
date of August 7, 2023, and such issue prices and stated redemption prices at maturity as set forth with respect to each Purchaser
in Schedule III hereto. In connection with any permitted transfer of a Warrant in compliance with the terms of the Warrant
and the Warrant Agency Agreement, the transferor shall cause the transferee to acknowledge and agree to the tax treatment for the
Warrants pursuant to this Section 4.3 and shall share Schedule III hereto with the transferee.

 

4.4             
Tax Reporting. The Company does not intend to issue IRS Form 1099-DIV to the Purchasers with respect to accruals
of dividends in respect of the Series A Shares that are not paid in cash.

 

4.5             
Entire Agreement. This Agreement, together with the exhibits and schedules hereto, contain the entire understanding
of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

    	 	24	 

     

    

 

4.6             
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder
shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or
communication is delivered via electronic mail at or prior to 5:30 p.m. (New York City time) on a day on which the NYSE is open
for trading (“Trading Day”), (b) the next Trading Day after the date of transmission, if such notice or communication
is delivered via electronic mail on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading
Day, (c) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service
or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications
shall be as set forth on the signature pages attached hereto.

 

4.7             
Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a
written instrument signed by the Company, the Operating Partnership and each of the Purchasers. No waiver of any default with respect
to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver
of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission
of any party to exercise any right hereunder in any manner impair the exercise of any such right.

 

4.8             
Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not
be deemed to limit or affect any of the provisions hereof.

 

4.9             
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. No party to this Agreement may assign this Agreement or any rights or obligations hereunder without the
prior written consent of each other party to this Agreement (other than by merger). Notwithstanding the foregoing, no prior written
consent shall be required for any Purchaser to assign this Agreement or any rights or obligations hereunder to a Purchaser/Affiliate.

 

4.10         
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to
the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal
courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of this Agreement),
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for
such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such
suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to
serve process in any other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any
provisions of this Agreement, then the prevailing party in such action, suit or proceeding shall be reimbursed by the other party
for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such action or proceeding.

 

    	 	25	 

     

    

 

4.11         
Survival of Agreements and Representations and Warranties. Notwithstanding any investigation made by any party to
this Agreement, all covenants and agreements made by the Company, the Operating Partnership and the Purchasers herein shall survive
the execution of this Agreement, the delivery to the Purchasers of the Securities and the payment therefor. All representations
and warranties, made by the Company, the Operating Partnership and the Purchasers herein shall survive the execution of this Agreement,
the delivery to the Purchasers of the Securities and the payment therefor.

 

4.12         
Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be
considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is
delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create
a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect
as if such facsimile or “.pdf” signature page were an original thereof.

 

4.13         
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein
shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use
their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result
as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention
of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any
of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

4.14         
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery
of damages, the Purchasers and the Company will be entitled to specific performance under this Agreement. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in this
Agreement and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense
that a remedy at law would be adequate.

 

4.15         
Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity
to revise this Agreement and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved
against the drafting party shall not be employed in the interpretation of this Agreement or any amendments thereto.

 

4.16         
WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY
OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY,
UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

 

(Signature Pages Follow)

 

    	 	26	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	GREAT AJAX CORP.	Address for Notice:
	 	 
		9400 SW Beaverton-Hillsdale Hwy,
		Suite 131
		Beaverton, Oregon 97005
		Attn: Lawrence Mendelsohn
		Email: larry@aspencapital.com

 

	By:	/s/ Lawrence Mendelsohn 	
		Name:	Lawrence Mendelsohn	 
		Title:	Chief Executive Officer	 

 

	GREAT AJAX OPERATING PARTNERSHIP L.P.	Address for Notice:
	 	 
		9400 SW Beaverton-Hillsdale Hwy
		Suite 131
		Beaverton, Oregon 97005
		Attn: Lawrence Mendelsohn
		Email: larry@aspencapital.com

 

	By:	/s/ Lawrence Mendelsohn 	
		Name:	Lawrence Mendelsohn	 
		Title:	Member	 

 

	THETIS ASSET MANAGEMENT LLC	Address for Notice:
	 	 
		9400 SW Beaverton-Hillsdale Hwy
		Suite 131
		Beaverton, Oregon 97005
		Attn: Lawrence Mendelsohn
		Email: larry@aspencapital.com

 

	By:	/s/ Lawrence Mendelsohn 	
		Name:	Lawrence Mendelsohn	 
		Title:	Manager	 

 

With a copy to (which shall not constitute notice):

 

Anna T. Pinedo

Mayer Brown LLP

1221 Avenue of the Americas

New York, NY 10020

Tel: (212) 506-2275

Fax: (212) 849-5767

Email: apinedo@mayerbrown.com

 

    	Signature Page to Securities Purchase Agreement

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

FLEXPOINT SPECIAL ASSETS FUND, L.P.

 

	By:	Flexpoint Special Assets Management, L.P.
	Its:	General Partner
	 	 
	By:	Flexpoint Ultimate Special Assets Management, LLC
	Its:	General Partner

 

 

	By:	/s/ Stephen H. Haworth	
	Name:	Stephen H. Haworth	 
	Title:	Chief Financial Officer	 
	Email:	shaworth@flexpointford.com	 

Facsimile: 312-327-4525

 

Jurisdiction of Purchaser’s Executive Offices:
Illinois

 

Address for Notice to Purchaser:

 

c/o Flexpoint Ford LLC

676 N. Michigan Avenue, Suite 3300

Chicago, IL 60611

Telephone: 312-327-4520

Facsimile: 312-327-4525

Email: sbegleiter@flexpointford.com

 

With a copy to (which shall not constitute notice):

 

Kirkland & Ellis LLP

300 North LaSalle St.

Chicago, IL 60654

Telephone: 312-862-2000

Facsimile: 312-862-2200

Attention: Kevin W. Mausert, P.C.

 

EIN:

 

    	Signature Page to Securities Purchase Agreement

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

MAGNETAR CONSTELLATION FUND V LLC

 

By: MAGNETAR FINANCIAL LLC, its manager

 

	By:	/s/ Karl Wachter	 
	Name:	Karl Wachter	 
	Title:	General Counsel	 

 

Jurisdiction of Purchaser’s Executive Offices:
Illinois

 

Address for Notice to Purchaser:

 

Magnetar Constellation Fund V LLC

c/o Magnetar Financial LLC

1603 Orrington Avenue, 13th Floor

Evanston, Illinois 60201

Telephone: (847) 905-4400

Facsimile: (847) 269-2064

Email: fisecurity@magnetar.com

 

EIN: 47-2215628

 

    	Signature Page to Securities Purchase Agreement

     

    

  

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

MAGNETAR CONSTELLATION FUND V LTD

 

By: MAGNETAR FINANCIAL LLC, its investment manager

 

	By:	/s/ Karl Wachter	 
	Name:	Karl Wachter	 
	Title:	General Counsel	 

 

Jurisdiction of Purchaser’s Executive Offices:
Illinois

 

Address for Notice to Purchaser:

 

Magnetar Constellation Fund V Ltd

c/o Magnetar Financial LLC

1603 Orrington Avenue, 13th Floor

Evanston, Illinois 60201

Telephone: (847) 905-4400

Facsimile: (847) 269-2064

Email: fisecurity@magnetar.com

 

EIN: 98-1223751

 

    	Signature Page to Securities Purchase Agreement

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

MAGNETAR LONGHORN FUND LP

 

By: MAGNETAR FINANCIAL LLC, its investment manager

 

	By:	/s/ Karl Wachter	 
	Name:	Karl Wachter	 
	Title:	General Counsel	 

 

Jurisdiction of Purchaser’s Executive Offices:
Illinois

 

Address for Notice to Purchaser:

 

Magnetar Longhorn Fund LP

c/o Magnetar Financial LLC

1603 Orrington Avenue, 13th Floor

Evanston, Illinois 60201

Telephone: (847) 905-4400

Facsimile: (847) 269-2064

Email: fisecurity@magnetar.com

 

EIN: 83-2065960

 

    	Signature Page to Securities Purchase Agreement

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

MAGNETAR STRUCTURED CREDIT FUND, LP

 

By: MAGNETAR FINANCIAL LLC, its general partner

 

	By:	/s/ Karl Wachter	 
	Name:	Karl Wachter	 
	Title:	General Counsel	 

 

Jurisdiction of Purchaser’s Executive Offices:
Illinois

 

Address for Notice to Purchaser:

 

Magnetar Structured Credit Fund, LP

c/o Magnetar Financial LLC

1603 Orrington Avenue, 13th Floor

Evanston, Illinois 60201

Telephone: (847) 905-4400

Facsimile: (847) 269-2064

Email: fisecurity@magnetar.com

 

EIN: 32-0236706

 

    	Signature Page to Securities Purchase Agreement

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

ITHAN CREEK MASTER INVESTORS (CAYMAN) L.P. 

 

By: Wellington Management Company LLP, as investment advisor

 

	By:	/s/ Peter McIsaac

	 
	Name:	Peter McIsaac	 
	Title:	Managing Director & Counsel	 
	Email:	 	 
	Facsimile: 	  	 

 

Jurisdiction of Purchaser’s Executive Offices:
Cayman

 

Address for Notice to Purchaser:

 

Ithan Creek Master Investors (Cayman) L.P.

c/o Wellington Management Company LLP

Legal and Compliance

280 Congress Street

Boston, MA 02210

Telephone Number: (617) 790-7429

Attn: Peter McIsaac

E-mail: #legal-ecm@wellington.com

 

 

EIN:

 

    	Signature Page to Securities Purchase Agreement

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

BAY POND PARTNERS, L.P.

 

By: Wellington Management Company LLP, as investment advisor

 

	By:	/s/ Peter McIsaac

	 
	Name:	Peter McIsaac	 
	Title:	Managing Director & Counsel	 
	Email:	 	 
	Facsimile: 	 	 

 

Jurisdiction of Purchaser’s Executive Offices:
Delaware

 

Address for Notice to Purchaser:

 

Bay Pond Partners, L.P.

c/o Wellington Management Company LLP

Legal and Compliance

280 Congress Street

Boston, MA 02210

Telephone Number: (617) 790-7429

Attn: Peter McIsaac

E-mail: #legal-ecm@wellington.com

 

EIN:

 

    	Signature Page to Securities Purchase Agreement

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above (joinder in this Securities Purchase Agreement by the undersigned is solely for purposes of
Section 4.1).

 

MAGNETAR SC FUND LTD

 

By: MAGNETAR FINANCIAL LLC, its investment manager

 

	By:	/s/ Karl Wachter	 
	Name:	Karl Wachter	 
	Title:	General Counsel	 
	Email:	fisecuritynotices@magnetar.com	 
	Facsimile: 	(847) 269-2064	 

 

Jurisdiction of Purchaser’s Executive Offices:
Illinois

 

Address for Notice to Purchaser:

 

Magnetar SC Fund Ltd

c/o Magnetar Financial LLC

1603 Orrington Avenue, 13th Floor

Evanston, Illinois 60201

Telephone: (847) 905-4400

Facsimile: (847) 269-2064

Email: fisecurity@magnetar.com

 

EIN:

 

    	Signature Page to Securities Purchase Agreement

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above (joinder in this Securities Purchase Agreement by the undersigned is solely for purposes of
Section 4.1).

 

MAGNETAR XING HE MASTER FUND LTD

 

By: MAGNETAR FINANCIAL LLC, its investment manager

 

	By:	/s/ Karl Wachter	 
	Name:	Karl Wachter	 
	Title:	General Counsel	 
	Email:	fisecuritynotices@magnetar.com	 
	Facsimile: 	(847) 269-2064	 

 

Jurisdiction of Purchaser’s Executive Offices:
Illinois

 

Address for Notice to Purchaser:

 

Magnetar Xing He Master Fund Ltd

c/o Magnetar Financial LLC

1603 Orrington Avenue, 13th Floor

Evanston, Illinois 60201

Telephone: (847) 905-4400

Facsimile: (847) 269-2064

Email: fisecurity@magnetar.com

 

EIN:

 

    	Signature Page to Securities Purchase Agreement

     

    

 

SCHEDULE I

 

Purchasers

 

 

	Purchaser	 	Number of
 Series A

                                                                                Shares
	 	 	Number of
 Series B

                                                                                Shares
	 	 	Number of

                                                                                Series A
 Warrants
	 	 	Number of

                                                                                                                              Series B

                                                                                Warrants
	 	 	Purchase

                                                                                Price
	 
	Bay Pond Partners, L.P.	 	 	200,000	 	 	 	 	 	 	 	250,000	 	 	 	 	 	 	$	5,000,000	 
	Flexpoint Special Assets Fund, L.P.	 	 	400,000	 	 	 	 	 	 	 	500,000	 	 	 	 	 	 	$	10,000,000	 
	Ithan Creek Master Investors (Cayman) L.P.	 	 	140,000	 	 	 	 	 	 	 	175,000	 	 	 	 	 	 	$	3,500,000	 
	Magnetar Constellation Fund V LLC	 	 	96,400	 	 	 	 	 	 	 	120,500	 	 	 	 	 	 	$	2,410,000	 
	Magnetar Constellation Fund V Ltd.	 	 	 	 	 	 	87,600	 	 	 	 	 	 	 	109,500	 	 	$	2,190,000	 
	Magnetar Longhorn Fund LP	 	 	87,600	 	 	 	 	 	 	 	109,500	 	 	 	 	 	 	$	2,190,000	 
	Magnetar Structured Credit Fund, LP	 	 	188,400	 	 	 	 	 	 	 	235,500	 	 	 	 	 	 	$	4,710,000	 
	Total	 	 	1,112,400	 	 	 	87,600	 	 	 	1,390,500	 	 	 	109,500	 	 	$	30,000,000	 

 

    	Schedule I

     

    

 

SCHEDULE II

 

Subsidiaries

 

Great Ajax Operating LLC

 

Great Ajax Operating Partnership L.P.

 

GA-TRS LLC

 

Great Ajax Funding LLC

 

AJX Mortgage Trust I

 

AJX Mortgage Trust II

 

GAJX Real Estate LLC

 

Great Ajax II Operating Partnership LP

 

Great Ajax II REIT Inc.

 

Great Ajax II Depositor LLC

 

    	Schedule II

     

    

 

SCHEDULE III

 

Tax Issue Price and Stated Redemption
Price at Maturity

 

	Purchaser	 	Tax Issue Price	 	 	Stated Redemption

                                                                                Price at Maturity
	 
	Bay Pond Partners, L.P.	 	$	377,964.32	 	 	$	1,746,875.00	 
	Flexpoint Special Assets Fund, L.P.	 	$	755,928.64	 	 	$	3,493,750.00	 
	Ithan Creek Master Investors (Cayman) L.P.	 	$	264,575.02	 	 	$	1,222,812.50	 
	Magnetar Constellation Fund V LLC	 	$	182,178.80	 	 	$	841,993.75	 
	Magnetar Constellation Fund V Ltd.	 	$	167,258.28	 	 	$	925,275.00	 
	Magnetar Longhorn Fund LP	 	$	165,548.37	 	 	$	765,131.25	 
	Magnetar Structured Credit Fund, LP	 	$	356,042.39	 	 	$	1,645,556.25	 

 

    	Schedule III

     

    

 

EXHIBIT A

 

FORM OF SERIES A WARRANT

 

    	 

     

    

 

EXHIBIT B

 

FORM OF SERIES B WARRANT

 

    	 

     

    

 

EXHIBIT C

 

FORM OF REGISTRATION RIGHTS AGREEMENT

 

    	 

     

    

 

EXHIBIT D

 

FORM OF OPINION OF MAYER BROWN LLP

 

 

1.                 
The Company is a corporation duly incorporated and validly existing under and by virtue of the laws of the State of Maryland
and is in good standing with the State Department of Assessments and Taxation of Maryland. The Company has all corporate power
and authority to execute, deliver and perform each of the Transaction Agreements to which it is a party.

 

2.                 
The Manager is duly organized and validly existing as a limited liability company and in good standing under the laws of
the State of Delaware. The Manager has all limited liability company power and authority to execute, deliver and perform each of
the Transaction Agreements to which it is a party.

 

3.                 
Each Significant Subsidiary is duly incorporated, organized and validly existing as a corporation, limited partnership or
limited liability company and in good standing, under the laws of its jurisdiction of organization. The Operating Partnership has
all limited partnership power and authority to execute, deliver and perform each of the Transaction Agreements to which it is a
party.

 

4.                 
The execution, delivery and performance by each of the Ajax Parties, as the case may be, of each of the Transaction Agreements
to which such entity is a party have each been duly authorized by all necessary corporate, limited liability company or limited
partnership action, as applicable, of such entity, and each of the Transaction Agreements to which each such entity is a party
has been duly executed and delivered on behalf of the Company and the Operating Partnership, as applicable.

 

5.                 
Assuming due authorization, execution and delivery by the other parties thereto, each of the Transaction Agreements to which
any of the Ajax Parties is a party constitutes a valid and binding obligation of such Ajax Party, as applicable, enforceable against
it, as applicable, in accordance with the terms of such Transaction Agreement.

 

6.                 
The shares of Preferred Stock have been duly authorized by all necessary corporate action of the Company and, when issued
in accordance with the provisions of the Securities Purchase Agreement, will be validly issued, fully paid and non-assessable,
free and clear of any pledge, lien, encumbrance, security interest or other claim.

 

7.                 
The Warrants have been duly authorized by all necessary corporate action of the Company and, when duly executed and delivered
in accordance with the provisions of the Warrant Agency Agreement, constitute valid and binding obligations of the Company, enforceable
against the Company in accordance with their terms.

 

8.                 
The Warrant Shares have been duly authorized by all necessary corporate action of the Company and reserved for issuance
upon exercise of the Warrants and, when issued and delivered against payment therefor pursuant to the Warrants, will be validly
issued, fully-paid and non-assessable.

 

    	Exhibit D-1

     

    

 

9.                 
The execution, delivery and performance by each of the Ajax Parties of each of the Transaction Agreements to which it is
a party, the issuance, sale and delivery of the Shares, the Warrants and the Warrant Shares (assuming valid and proper exercise
of the Warrants in accordance with the terms of the Warrant Agency Agremeent), by the Company, the consummation by the Ajax Parties
of the transactions contemplated by the Transaction Agreements, and compliance by the Ajax Parties with the terms and provisions
of the Transaction Agreements do not (a) require any consent, approval, license, authorization or validation of, or filing, recording
or registration with, any executive, legislative, judicial, administrative or regulatory body, other than as have been obtained
or made and are in full force and effect or (b) conflict with, or result in any breach of or constitute a default under (nor constitute
any event which with notice, lapse of time, or both would constitute a breach of, or default under), (i) any provision of its organizational
documents, (ii) any provision of any license, indenture, mortgage, deed of trust, bank loan or credit agreement or other agreement
or instrument to which any of the Ajax Parties is a party or by which it or its respective properties may be bound or affected,
or (iii) any U.S. federal, state, local or foreign law, regulation or rule or any decree, judgment, permit or order applicable
to any of the Ajax Parties or its properties, except in the case of clauses (a) or (b)(ii) or (b)(iii) for such conflicts, breaches
or defaults which have been validly waived or would not reasonably be expected to have a Material Adverse Effect or result in the
creation or imposition of any material lien, charge, claim or encumbrance upon any property or asset of the Company.

 

10.             
The filing of the Second Closing Articles Supplementary and the Articles of Amendment relating to each of the Series A Preferred
Stock and the Series B Preferred Stock has been duly authorized by all necessary corporation action on the part of the Company.

 

11.             
Assuming the accuracy of the representations and warranties of the Purchasers contained in the Securities Purchase Agreement,
the offer and sale of the Preferred Stock and the Warrants by the Company to the Purchasers and the issuance of the Warrant Shares
upon exercise of the Warrants are exempt from the registration requirements of the Securities Act of 1933, as amended.

 

12.             
Each of the Company and the Operating Partnership and the Significant Subsidiaries is not, and immediately after giving
effect to the issuance and sale of the Preferred Stock and the Warrants occurring today and the application of proceeds therefrom
as described in the Securities Purchase Agreement, will not be, an “investment company” within the meaning of said
term as used in the Investment Company Act of 1940, as amended.

 

    	Exhibit D-2

     

    

 

APPENDIX I

 

RESALE REGISTRATION STATEMENT QUESTIONNAIRE

 

In connection with the preparation of the
Registration Statement, please provide us with the following information:

 

SECTION 1.Pursuant
to the “Selling Stockholder” section of the Registration Statement, please state [your] / [your organization’s]
name exactly as it should appear in the Registration Statement:

 

SECTION 2.Please
provide the number of shares that [you] / [your organization] will own immediately after Closing, including those [Shares] / [Warrant
Shares] purchased by [you] / [your organization] pursuant to this Securities Purchase Agreement and those shares purchased by [you]
/ [your organization] through other transactions and provide the number of shares that [you] / [your organization] has the right
to acquire within 60 days of Closing:

 

SECTION 3.[Have
you] / [Has your organization] had any position, office or other material relationship within the past three years with the Company
or its affiliates?

 

 ̈
Yes           ̈  No

 

 

If “yes,” please indicate the nature of any such
relationships below:

 

SECTION 4.(a) Are
you (i) a FINRA Member (see definition), (ii) a Controlling (see definition) shareholder of a FINRA Member, (iii) a Person Associated
with a Member of the FINRA (see definition), or (iv) an Underwriter or a Related Person (see definition below) with respect to
the proposed offering; (b) do you own any shares or other securities of any FINRA Member not purchased in the open market; or (c)
have you made any outstanding subordinated loans to any FINRA Member?

 

Answer:  ̈
Yes  ̈  No If “yes,” please describe below

 

 

 

 

 

 

FINRA Member.
The term “FINRA Member” means either any broker or dealer admitted to membership in the Financial Industry Regulatory
Authority (“FINRA”). (FINRA Manual, By-laws of FINRA Regulation, Inc. Article I, Definitions)

 

Control. The
term “control” (including the terms “controlling,” “controlled by” and “under common
control with”) means the possession, direct or indirect, of the power, either individually or with others, to direct or cause
the direction of the management and policies of a person, whether through the ownership of voting securities, by contract, or otherwise.
(Rule 405 under the Securities Act of 1933, as amended)

 

Person Associated
with a member of the FINRA. The term “person associated with a member of the FINRA” means every sole proprietor,
partner, officer, director, branch manager or executive representative of any FINRA Member, or any natural person occupying a similar
status or performing similar functions, or any natural person engaged in the investment banking or securities business who is directly
or indirectly controlling or controlled by a FINRA Member, whether or not such person is registered or exempt from registration
with the FINRA pursuant to its bylaws. (FINRA Manual, By-laws of FINRA Regulation, Inc. Article I, Definitions)

 

Underwriter or a
Related Person. The term “underwriter or a related person” means, with respect to a proposed offering, underwriters,
underwriters’ counsel, financial consultants and advisors, finders, members of the selling or distribution group, and any
and all other persons associated with or related to any of such persons. (FINRA Interpretation).

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}]]